Interconnect for on-body analyte monitoring device

Description

FIELD OF THE INVENTION

The present invention relates to an analyte monitoring system. More particularly, the present invention relates to apparatus for establishing electrical communication between an analyte sensor and an electronics unit in an on-body analyte monitoring device.

BACKGROUND OF THE INVENTION

The detection and/or monitoring of glucose levels or other analytes, such as lactate, oxygen, A1C, or the like, in certain individuals is vitally important to their health. For example, the monitoring of glucose is particularly important to individuals with diabetes. Diabetics generally monitor glucose levels to determine if their glucose levels are being maintained within a clinically safe range, and may also use this information to determine if and/or when insulin is needed to reduce glucose levels in their bodies or when additional glucose is needed to raise the level of glucose in their bodies.

Growing clinical data demonstrates a strong correlation between the frequency of glucose monitoring and glycemic control. Despite such correlation, many individuals diagnosed with a diabetic condition do not monitor their glucose levels as frequently as they should due to a combination of factors including convenience, testing discretion, pain associated with glucose testing, and cost.

Devices have been developed for the automatic monitoring of analyte(s), such as glucose, in bodily fluid such as in the blood stream or in interstitial fluid (“ISF”), or other biological fluid. Some of these analyte measuring devices are configured so that at least a portion of the devices are positioned below a skin surface of a user, e.g., in a blood vessel or in the subcutaneous tissue of a user, so that the monitoring is accomplished in vivo.

With the continued development of analyte monitoring devices and systems, there is a need for such analyte monitoring devices, systems, and methods, as well as for processes for manufacturing analyte monitoring devices and systems that are cost effective, convenient, and with reduced pain, provide discreet monitoring to encourage frequent analyte monitoring to improve glycemic control.

Typically, a glucose monitor consists of an analyte sensor that is implanted in a patient and an electronics unit adapted to establish electrical communication with the analyte sensor. The electrical communication may be accomplished utilizing a number of different interconnects. For example, some electronics units utilize pogo pins, polymer pins, solid pins, or springs as interconnects. However, each of these known interconnects has potential drawbacks. For example, pogo pins are not durable, and moisture can seep into the spring mechanism, thereby degrading their performance. Similarly, polymer pins can degrade and wear after multiple cleanings Solid pins generally require extensive modification of existing systems, leading to higher costs for the patient. Spring connections are delicate, and may be prone to failure after extended use. Therefore, there clearly exists a need for a low-cost, waterproof, flexible interconnect that allows for efficient and reliable electrical communication between an analyte sensor and an electronics unit.

In other instances, a user may need to wear an on-body analyte monitoring device for an extended period of time. Generally, the on-body monitoring device includes a mounting unit housing an analyte sensor and an electronics unit. However, such devices can be bulky and uncomfortable due to the size and vertical height (“Z-height”) of the electronics unit and the size of the mounting unit, which should be sufficiently large to house the electronics unit. Therefore, there exists a need for an on-body analyte monitoring device having a streamlined body and low profile (e.g., reduced Z-height) for a more comfortable wear and patient compliance.

SUMMARY OF THE INVENTION

Generally, the present invention relates to an interconnect configured to establish electrical communication between an analyte sensor and an electronics unit. The analyte sensor, interconnect, and the electronics unit define an on-body analyte monitoring device having a low profile. The on-body analyte monitoring device can be used with analyte monitoring system, such as for example, a continuous glucose monitoring system or analyte measurement system which provides analyte levels on demand. An analyte monitoring system generally includes an on-body analyte monitoring device and one or more receiver/display units. Optionally, the analyte monitoring system can further include a data processing unit, such as for example a CPU. Thus, in one embodiment, the on-body analyte monitoring device comprises an analyte sensor for measuring analyte levels, an electronics unit adapted to process the signals relating to the analyte levels generated by the analyte sensor, and an interconnect adapted to establish electrical conductivity between the electronics unit and the analyte sensor.

In one embodiment, the electronics unit includes a processor disposed within the body of the electronics unit. The processor can comprise an application specific integrated circuit (ASIC). In some embodiments, an elongate interconnect is coupled to the body of the electronics unit, such as for example the sidewall of the electronics unit proximate an analyte sensor. In some embodiments, the elongate interconnect can extend laterally from the electronics unit so as to contact an analyte sensor disposed adjacent the electronics unit.

The elongate interconnect comprises conductive material, such as, but not limited to, conductive cables, such as ribbon cables. In some embodiments, the conductive material can be embedded or etched in a flexible material, such as a flexible strip of thermoplastic material. The flexible strip may be formed from any suitable thermoplastic material. For example, the thermoplastic material includes polyimides such as Apical, Kapton, UPILEX, VTEC PI, Norton TH, polyester, mylar, and Kaptrex. However, in other embodiments, the conductive material can be encapsulated in a flexible sheath.

In some embodiments, the elongate interconnect is coupled to the electronics unit, for example, to a circuit board disposed in the body of the electronics unit, to establish electrical communication between the electronics unit and interconnect. Additionally, the elongate interconnect can establish electrical communication with an analyte sensor. In some embodiments, the elongate interconnect can include a conductive material such as a conductive contact to contact or otherwise couple to the analyte sensor, thereby establishing electrical communication between the interconnect and the analyte sensor. In some embodiments, the elongate interconnect is formed of a flexible material such that the extended length of the interconnect can collapse or otherwise deform when the electronics unit is coupled to the analyte sensor. Upon disengagement of the analyte sensor and the electronics unit, the elongate interconnect can return to its non-collapsed configuration.

The analyte sensor, for example, in some embodiments, includes a substrate having conductive material, such as one or more electrodes and one or more conductive contacts. In some embodiments, the conductive material comprises gold, which can be formed using ablation techniques (e.g., laser ablation). The analyte sensor can be configured to monitor glucose levels or any other analyte of interest, including drugs.

In some embodiments, the electronics unit may further comprise a seal disposed proximate the elongate interconnect. The seal may be an individual molded component made of low durometer silicone, rubber or some other material TPE. In some embodiments, the interconnect extends approximately 1 mm beyond the face of the seal. When the electronics unit is locked into position, the interconnect compresses and makes contact with the conductive pads on the sensor. The seal also compresses to form a barrier around the perimeter of the interconnect/sensor connection. The interconnect may work without the seal, however once liquid or dust got in, the interconnect/sensor interface may be compromised and fail.

In some embodiments, the seal includes an opening to permit direct contact of a conductive contact disposed on the interconnect to the analyte sensor. In this manner, the analyte sensor and the electronics unit can establish electrical conductivity via the closed circuit provided by the interconnect.

In another aspect of the invention, an on-body analyte monitoring device having a reduced vertical height is provided. In one embodiment, the interconnect includes a top surface and a bottom surface adapted to engage, for example, interlock, with the body of the electronics unit. The interconnect includes conductive material, which establishes electrical communication with and between both an analyte sensor and an electronics unit. In some embodiments, the electronics unit may comprise a circuit board for interfacing with a conductive area of the interconnect thereby establishing electrical communication between the interconnect and the electronics unit. Thus, when interconnect is engaged to the electronics unit, the conductive material or areas of the interconnect form a closed circuitry with the electronics unit and the analyte sensor, thereby establishing electrical communication between the analyte sensor and the electronics unit.

In some embodiments, the conductive material includes a conductive film, such as an anisotropic film or an elastomeric connector, such as a Zebra® style connector. Alternatively, the first and second conductive material can include clips.

In one embodiment, the conductive surfaces can further include an adhesive for adhering the electronics unit and analyte sensor to the interconnect. The adhesive can be a UV curable adhesive or any other suitable adhesive. Other examples include a multi-adhesive system, such as a silver loaded epoxy, which allows for the electronics unit and analyte sensor to be adhered together while also placing the electronics unit and analyte sensor in electrical communication.

The interconnect can also include a power source, such as a battery to power the electronics unit. In this manner, the electronics unit can be configured without its own internal power supply.

In some embodiments, the bottom surface of the interconnect includes an adhesive surface capable of bonding with human skin. Accordingly, the interconnect can also serve as a mounting unit to adhere the on-body device to a subject, such that a separate mounting unit component is not required.

In some embodiments, the interconnect is configured to engage the electronics unit to define a two-component on-body monitoring device. In other embodiments, the interconnect, sensor, and electronics unit are integrated to define a single component on-body monitoring device.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1A illustrates a block diagram of a data monitoring and management system for practicing one or more embodiments of the present invention;

FIG. 1B illustrates a schematic diagram of the elements of FIG. 1A;

FIG. 2 illustrates a schematic view of an electronics unit according to one or more embodiments of the present invention;

FIG. 3 illustrates a schematic view of the elongate interconnect of the electronics unit of FIG. 2 in a flat position;

FIG. 4 illustrates a schematic view of the electronics unit of FIG. 2 when it is in contact with an analyte sensor;

FIGS. 5A-5D depict various elongate interconnects compatible with one or more embodiments of the present invention;

FIG. 6 depicts a pictorial view of an analyte monitoring device according to another embodiment of the present invention;

FIG. 7A depicts a pictorial view of the analyte monitoring device of FIG. 6 when it is disassembled;

FIG. 7B depicts a bottom view of the on-body analyte monitoring device of FIG. 7A;

FIG. 8 depicts the interconnect of FIG. 7B with the battery and analyte sensor removed.

DETAILED DESCRIPTION OF THE EMBODIMENTS

Before the present disclosure is described in detail, it is to be understood that this disclosure is not limited to particular embodiments described, as such may, of course, vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to be limiting, since the scope of the present disclosure will be limited only by the appended claims.

Where a range of values is provided, it is understood that each intervening value, to the tenth of the unit of the lower limit unless the context clearly dictates otherwise, between the upper and lower limit of that range and any other stated or intervening value in that stated range, is encompassed within the disclosure. The upper and lower limits of these smaller ranges may independently be included in the smaller ranges as also encompassed within the disclosure, subject to any specifically excluded limit in the stated range. Where the stated range includes one or both of the limits, ranges excluding either or both of those included limits are also included in the disclosure.

Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this disclosure belongs. Although any methods and materials similar or equivalent to those described herein can also be used in the practice or testing of the present disclosure, the preferred methods and materials are now described. All publications mentioned herein are incorporated herein by reference to disclose and describe the methods and/or materials in connection with which the publications are cited.

It must be noted that as used herein and in the appended claims, the singular forms “a”, “an”, and “the” include plural referents unless the context clearly dictates otherwise.

The publications discussed herein are provided solely for their disclosure prior to the filing date of the present application. Nothing herein is to be construed as an admission that the present disclosure is not entitled to antedate such publication by virtue of prior disclosure.

Further, the dates of publication provided may be different from the actual publication dates which may need to be independently confirmed.

As will be apparent to those of skill in the art upon reading this disclosure, each of the individual embodiments described and illustrated herein has discrete components and features which may be readily separated from or combined with the features of any of the other several embodiments without departing from the scope or spirit of the present disclosure.

The figures shown herein are not necessarily drawn to scale, with some components and features being exaggerated for clarity.

Generally, embodiments of the present disclosure relate to in vivo methods and devices for detecting at least one analyte such as glucose in body fluid. Accordingly, embodiments include in vivo analyte sensors configured so that at least a portion of the sensor is positioned in the body of a user (e.g., within the ISF), to obtain information about at least one analyte of the body, e.g., transcutaneously positioned in user's body. In certain embodiments, an in vivo analyte sensor is coupled to an electronics unit that is maintained on the body of the user such as on a skin surface, where such coupling provides on body, in vivo analyte sensor electronics assemblies.

In certain embodiments, analyte information is communicated from a first device such as an on body electronics unit to a second device which may include user interface features, including a display, and/or the like. Information may be communicated from the first device to the second device automatically and/or continuously when the analyte information is available, or may not be communicated automatically and/or continuously, but rather stored or logged in a memory of the first device. Accordingly, in many embodiments of the system, analyte information derived by the sensor/on body electronics (for example, on body electronics assembly) is made available in a user-usable or viewable form only when queried by the user such that the timing of data communication is selected by the user.

In this manner, analyte information is only provided or evident to a user (provided at a user interface device) when desired by the user even though an in vivo analyte sensor automatically and/or continuously monitors the analyte level in vivo, i.e., the sensor automatically monitors analyte such as glucose on a pre-defined time interval over its usage life. For example, an analyte sensor may be positioned in vivo and coupled to on body electronics for a given sensing period, e.g., about 14 days. In certain embodiments, the sensor-derived analyte information is automatically communicated from the sensor electronics assembly to a remote monitor device or display device for output to a user throughout the 14 day period according to a schedule programmed at the on body electronics (e.g., about every 1 minute or about every 5 minutes or about every 10 minutes, or the like). In certain embodiments, sensor-derived analyte information is only communicated from the sensor electronics assembly to a remote monitor device or display device at user-determined times, e.g., whenever a user decides to check analyte information. At such times, a communications system is activated, and sensor-derived information is then sent from the on body electronics to the remote device or display device.

In still other embodiments, the information may be communicated from the first device to the second device automatically and/or continuously when the analyte information is available, and the second device stores or logs the received information without presenting or outputting the information to the user. In such embodiments, the information is received by the second device from the first device when the information becomes available (e.g., when the sensor detects the analyte level according to a time schedule). However, the received information is initially stored in the second device and only output to a user interface or an output component of the second device (e.g., display) upon detection of a request for the information on the second device.

Accordingly, in certain embodiments once a sensor electronics assembly is placed on the body so that at least a portion of the in vivo sensor is in contact with bodily fluid such as ISF and the sensor is electrically coupled to the electronics unit, sensor derived analyte information may be communicated from the on body electronics to a display device on-demand by powering on the display device (or it may be continually powered), and executing a software algorithm stored in and accessed from a memory of the display device, to generate one or more request commands, control signal or data packet to send to the on body electronics. The software algorithm executed under, for example, the control of the microprocessor or application specific integrated circuit (ASIC) of the display device may include routines to detect the position of the on body electronics relative to the display device to initiate the transmission of the generated request command, control signal and/or data packet.

Display devices may also include programming stored in memory for execution by one or more microprocessors and/or ASICs to generate and transmit the one or more request command, control signal or data packet to send to the on body electronics in response to a user activation of an input mechanism on the display device such as depressing a button on the display device, triggering a soft button associated with the data communication function, and so on. The input mechanism may be alternatively or additionally provided on or in the on body electronics which may be configured for user activation. In certain embodiments, voice commands or audible signals may be used to prompt or instruct the microprocessor or ASIC to execute the software routine(s) stored in the memory to generate and transmit the one or more request command, control signal or data packet to the on body device. In the embodiments that are voice activated or responsive to voice commands or audible signals, on body electronics and/or display device includes a microphone, a speaker, and processing routines stored in the respective memories of the on body electronics and/or the display device to process the voice commands and/or audible signals. In certain embodiments, positioning the on body device and the display device within a predetermined distance (e.g., close proximity) relative to each other initiates one or more software routines stored in the memory of the display device to generate and transmit a request command, control signal or data packet.

Different types and/or forms and/or amounts of information may be sent for each on demand reading, including, but not limited to, one or more of current analyte level information (i.e., real time or the most recently obtained analyte level information temporally corresponding to the time the reading is initiated), rate of change of an analyte over a predetermined time period, rate of the rate of change of an analyte (acceleration in the rate of change), historical analyte information corresponding to analyte information obtained prior to a given reading and stored in memory of the assembly. Some or all of real time, historical, rate of change, rate of rate of change (such as acceleration or deceleration) information may be sent to a display device for a given reading. In certain embodiments, the type and/or form and/or amount of information sent to a display device may be preprogrammed and/or unchangeable (e.g., preset at manufacturing), or may not be preprogrammed and/or unchangeable so that it may be selectable and/or changeable in the field one or more times (e.g., by activating a switch of the system, etc.). Accordingly, in certain embodiments, for each on demand reading, a display device will output a current (real time) sensor-derived analyte value (e.g., in numerical format), a current rate of analyte change (e.g., in the form of an analyte rate indicator such as an arrow pointing in a direction to indicate the current rate), and analyte trend history data based on sensor readings acquired by and stored in memory of on body electronics (e.g., in the form of a graphical trace). Additionally, the on skin or sensor temperature reading or measurement associated with each on demand reading may be communicated from the on body electronics to the display device. The temperature reading or measurement, however, may not be output or displayed on the display device, but rather, used in conjunction with a software routine executed by the display device to correct or compensate the analyte measurement output to the user on the display device.

As described, embodiments include in vivo analyte sensors and on body electronics that together provide body wearable sensor electronics assemblies. In certain embodiments, in vivo analyte sensors are fully integrated with on body electronics (fixedly connected during manufacture), while in other embodiments they are separate but connectable post manufacture (e.g., before, during or after sensor insertion into a body). On body electronics may include an in vivo glucose sensor, electronics, battery, and antenna encased (except for the sensor portion that is for in vivo positioning) in a waterproof housing that includes or is attachable to an adhesive pad. In certain embodiments, the housing withstands immersion in about one meter of water for up to at least 30 minutes. In certain embodiments, the housing withstands continuous underwater contact, e.g., for longer than about 30 minutes, and continues to function properly according to its intended use, e.g., without water damage to the housing electronics where the housing is suitable for water submersion.

Embodiments include sensor insertion devices, which also may be referred to herein as sensor delivery units, or the like. Insertion devices may retain on body electronics assemblies completely in an interior compartment, i.e., an insertion device may be “pre-loaded” with on body electronics assemblies during the manufacturing process (e.g., on body electronics may be packaged in a sterile interior compartment of an insertion device). In such embodiments, insertion devices may form sensor assembly packages (including sterile packages) for pre-use or new on body electronics assemblies, and insertion devices configured to apply on body electronics assemblies to recipient bodies.

Embodiments include portable handheld display devices, as separate devices and spaced apart from an on body electronics assembly, that collect information from the assemblies and provide sensor derived analyte readings to users. Such devices may also be referred to as meters, readers, monitors, receivers, human interface devices, companions, or the like. Certain embodiments may include an integrated in vitro analyte meter. In certain embodiments, display devices include one or more wired or wireless communications ports such as USB, serial, parallel, or the like, configured to establish communication between a display device and another unit (e.g., on body electronics, power unit to recharge a battery, a PC, etc.). For example, a display device communication port may enable charging a display device battery with a respective charging cable and/or data exchange between a display device and its compatible informatics software.

Compatible informatics software in certain embodiments include, for example, but are not limited to, stand alone or network connection enabled data management software program, resident or running on a display device, personal computer, a server terminal, for example, to perform data analysis, charting, data storage, data archiving and data communication as well as data synchronization. Informatics software in certain embodiments may also include software for executing field upgradable functions to upgrade firmware of a display device and/or on body electronics unit to upgrade the resident software on the display device and/or the on body electronics unit, e.g., with versions of firmware that include additional features and/or include software bugs or errors fixed, etc.

Embodiments may include a haptic feedback feature such as a vibration motor or the like, configured so that corresponding notifications (e.g., a successful on-demand reading received at a display device), may be delivered in the form of haptic feedback.

Embodiments include programming embedded on a computer readable medium, i.e., computer-based application software (may also be referred to herein as informatics software or programming or the like) that processes analyte information obtained from the system and/or user self-reported data. Application software may be installed on a host computer such as a mobile telephone, PC, an Internet-enabled human interface device such as an Internet-enabled phone, personal digital assistant, or the like, by a display device or an on body electronics unit. Informatics programming may transform data acquired and stored on a display device or on body unit for use by a user.

Embodiments of the subject disclosure are described primarily with respect to glucose monitoring devices and systems, and methods of glucose monitoring, for convenience only and such description is in no way intended to limit the scope of the disclosure. It is to be understood that the analyte monitoring system may be configured to monitor a variety of analytes at the same time or at different times.

For example, analytes that may be monitored include, but are not limited to, acetyl choline, amylase, bilirubin, cholesterol, chorionic gonadotropin, creatine kinase (e.g., CK-MB), creatine, DNA, fructosamine, glucose, glutamine, growth hormones, hormones, ketones, lactate, oxygen, peroxide, prostate-specific antigen, prothrombin, RNA, thyroid stimulating hormone, and troponin. The concentration of drugs, such as, for example, antibiotics (e.g., gentamicin, vancomycin, and the like), digitoxin, digoxin, drugs of abuse, theophylline, and warfarin, may also be monitored. In those embodiments that monitor more than one analyte, the analytes may be monitored at the same or different times, with a single sensor or with a plurality of sensors which may use the same on body electronics (e.g., simultaneously) or with different on body electronics.

As described in detail below, embodiments include devices, systems, kits and/or methods to monitor one or more physiological parameters such as, for example, but not limited to, analyte levels, temperature levels, heart rate, user activity level, over a predetermined monitoring time period. Also provided are methods of manufacturing. Predetermined monitoring time periods may be less than about 1 hour, or may include about 1 hour or more, e.g., about a few hours or more, e.g., about a few days of more, e.g., about 3 or more days, e.g., about 5 days or more, e.g., about 7 days or more, e.g., about 10 days or more, e.g., about 14 days or more, e.g., about several weeks, e.g., about 1 month or more. In certain embodiments, after the expiration of the predetermined monitoring time period, one or more features of the system may be automatically deactivated or disabled at the on body electronics assembly and/or display device.

For example, a predetermined monitoring time period may begin with positioning the sensor in vivo and in contact with a body fluid such as ISF, and/or with the initiation (or powering on to full operational mode) of the on body electronics. Initialization of on body electronics may be implemented with a command generated and transmitted by a display device in response to the activation of a switch and/or by placing the display device within a predetermined distance (e.g., close proximity) to the on body electronics, or by user manual activation of a switch on the on body electronics unit, e.g., depressing a button, or such activation may be caused by the insertion device, e.g., as described in U.S. patent application Ser. No. 12/698,129, now U.S. Pat. No. 9,402,544, and U.S. Provisional Application Nos. 61/238,646, 61/246,825, 61/247,516, 61/249,535, 61/317,243, 61/345,562, and 61/361,374, the disclosures of each of which are incorporated herein by reference for all purposes.

When initialized in response to a received command from a display device, the on body electronics retrieves and executes from its memory software routine to fully power on the components of the on body electronics, effectively placing the on body electronics in full operational mode in response to receiving the activation command from the display device. For example, prior to the receipt of the command from the display device, a portion of the components in the on body electronics may be powered by its internal power supply such as a battery while another portion of the components in the on body electronics may be in powered down or low power including no power, inactive mode, or all components may be in an inactive mode, powered down mode. Upon receipt of the command, the remaining portion (or all) of the components of the on body electronics is switched to active, fully operational mode.

Embodiments of on body electronics may include one or more circuit boards with electronics including control logic implemented in ASIC, microprocessors, memory, and the like, and transcutaneously positionable analyte sensors forming a single assembly. On body electronics may be configured to provide one or more signals or data packets associated with a monitored analyte level upon detection of a display device of the analyte monitoring system within a predetermined proximity for a period of time (for example, about 2 minutes, e.g., 1 minute or less, e.g., about 30 seconds or less, e.g., about 10 seconds or less, e.g., about 5 seconds or less, e.g., about 2 seconds or less) and/or until a confirmation, such as an audible and/or visual and/or tactile (e.g., vibratory) notification, is output on the display device indicating successful acquisition of the analyte related signal from the on body electronics. A distinguishing notification may also be output for unsuccessful acquisition in certain embodiments.

In certain embodiments, the monitored analyte level may be correlated and/or converted to glucose levels in blood or other fluids such as ISF. Such conversion may be accomplished with the on body electronics, but in many embodiments will be accomplished with display device electronics. In certain embodiments, glucose level is derived from the monitored analyte level in the ISF.

Analyte sensors may be insertable into a vein, artery, or other portion of the body containing analyte. In certain embodiments, analyte sensors may be positioned in contact with ISF to detect the level of analyte, where the detected analyte level may be used to infer the user's glucose level in blood or interstitial tissue.

Embodiments include transcutaneous sensors and also wholly implantable sensors and wholly implantable assemblies in which a single assembly including the analyte sensor and electronics are provided in a sealed housing (e.g., hermetically sealed biocompatible housing) for implantation in a user's body for monitoring one or more physiological parameters.

Embodiments of In Vivo Analyte Monitoring Systems

FIGS. 1A and 1B show an exemplary in vivo-based analyte monitoring system 100 in accordance with embodiments of the present disclosure. As shown, in certain embodiments, analyte monitoring system 100 includes on body electronics 110 electrically coupled to in vivo analyte sensor 101 and attached to adhesive layer 140 for attachment on a skin surface on the body of a user. On body electronics 110 includes on body housing 119, that defines an interior compartment. Also shown in FIG. 1B is insertion device 150 that, when operated, transcutaneously positions a portion of analyte sensor 101 through a skin surface and in fluid contact with interstitial fluid, and positions on body electronics 110 and adhesive layer 140 on a skin surface. In certain embodiments, on body electronics 110, analyte sensor 101 and adhesive layer 140 are sealed within the housing of insertion device 150 before use, and in certain embodiments, adhesive layer 140 is also sealed within the housing or itself provides a terminal seal of the insertion device 150. Devices, systems and methods that may be used with embodiments herein are described, e.g., in U.S. patent application Ser. No. 12/698,129, now U.S. Pat. No. 9,402,544, and U.S. Provisional Application Nos. 61/238,646, 61/246,825, 61/247,516, 61/249,535, 61/317,243, 61/345,562, and 61/361,374, the disclosures of each of which are incorporated herein by reference for all purposes.

Referring back to the FIG. 1B, analyte monitoring system 100 includes display device 120 which includes a display 122 to output information to the user, an input component 121 such as a button, actuator, a touch sensitive switch, a capacitive switch, pressure sensitive switch, jog wheel or the like, to input data or command to display device 120 or otherwise control the operation of display device 120. It is noted that some embodiments may include display-less devices or devices without any user interface components. These devices may be functionalized to store data as a data logger and/or provide a conduit to transfer data from on body electronics and/or a display-less device to another device and/or location. Embodiments will be described herein as display devices for exemplary purposes which are in no way intended to limit the embodiments of the present disclosure. It will be apparent that display-less devices may also be used in certain embodiments.

In certain embodiments, on body electronics 110 may be configured to store some or all of the monitored analyte related data received from analyte sensor 101 in a memory during the monitoring time period, and maintain it in memory until the usage period ends. In such embodiments, stored data is retrieved from on body electronics 110 at the conclusion of the monitoring time period, for example, after removing analyte sensor 101 from the user by detaching on body electronics 110 from the skin surface where it was positioned during the monitoring time period. In such data logging configurations, real time monitored analyte level is not communicated to display device 120 during the monitoring period or otherwise transmitted from on body electronics 110, but rather, retrieved from on body electronics 110 after the monitoring time period.

In certain embodiments, input component 121 of display device 120 may include a microphone and display device 120 may include software configured to analyze audio input received from the microphone, such that functions and operation of the display device 120 may be controlled by voice commands. In certain embodiments, an output component of display device 120 includes a speaker for outputting information as audible signals. Similar voice responsive components such as a speaker, microphone and software routines to generate, process and store voice driven signals may be provided to on body electronics 110.

In certain embodiments, display 122 and input component 121 may be integrated into a single component, for example a display that can detect the presence and location of a physical contact touch upon the display such as a touch screen user interface. In such embodiments, the user may control the operation of display device 120 by utilizing a set of pre-programmed motion commands, including, but not limited to, single or double tapping the display, dragging a finger or instrument across the display, motioning multiple fingers or instruments toward one another, motioning multiple fingers or instruments away from one another, etc. In certain embodiments, a display includes a touch screen having areas of pixels with single or dual function capacitive elements that serve as LCD elements and touch sensors.

Display device 120 also includes data communication port 123 for wired data communication with external devices such as remote terminal (personal computer) 170, for example. Example embodiments of the data communication port 123 include USB port, mini USB port, RS-232 port, Ethernet port, Firewire port, or other similar data communication ports configured to connect to the compatible data cables. Display device 120 may also include an integrated in vitro glucose meter, including in vitro test strip port 124 to receive an in vitro glucose test strip for performing in vitro blood glucose measurements.

Referring still to FIG. 1B, display 122 in certain embodiments is configured to display a variety of information—some or all of which may be displayed at the same or different time on display 122. In certain embodiments the displayed information is user-selectable so that a user can customize the information shown on a given display screen. Display 122 may include but is not limited to graphical display 138, for example, providing a graphical output of glucose values over a monitored time period (which may show important markers such as meals, exercise, sleep, heart rate, blood pressure, etc., numerical display 132, for example, providing monitored glucose values (acquired or received in response to the request for the information), and trend or directional arrow display 131 that indicates a rate of analyte change and/or a rate of the rate of analyte change, e.g., by moving locations on display 122.

As further shown in FIG. 1B, display 122 may also include date display 135 providing for example, date information for the user, time of day information display 139 providing time of day information to the user, battery level indicator display 133 which graphically shows the condition of the battery (rechargeable or disposable) of the display device 120, sensor calibration status icon display 134 for example, in monitoring systems that require periodic, routine or a predetermined number of user calibration events, notifying the user that the analyte sensor calibration is necessary, audio/vibratory settings icon display 136 for displaying the status of the audio/vibratory output or alarm state, and wireless connectivity status icon display 137 that provides indication of wireless communication connection with other devices such as on body electronics, data processing module 160, and/or remote terminal 170. As additionally shown in FIG. 1B, display 122 may further include simulated touch screen button 125, 126 for accessing menus, changing display graph output configurations or otherwise for controlling the operation of display device 120.

Referring back to FIG. 1B, in certain embodiments, display 122 of display device 120 may be additionally, or instead of visual display, configured to output alarms notifications such as alarm and/or alert notifications, glucose values etc., which may be audible, tactile, or any combination thereof. In one aspect, the display device 120 may include other output components such as a speaker, vibratory output component and the like to provide audible and/or vibratory output indication to the user in addition to the visual output indication provided on display 122. Further details and other display embodiments can be found in, e.g., U.S. patent application Ser. No. 12/871,901, now U.S. Pat. No. 8,514,086, U.S. Provisional Application Nos. 61/238,672, 61/247,541, 61/297,625, the disclosures of each of which are incorporated herein by reference for all purposes.

After the positioning of on body electronics 110 on the skin surface and analyte sensor 101 in vivo to establish fluid contact with interstitial fluid (or other appropriate body fluid), on body electronics 110 in certain embodiments is configured to wirelessly communicate analyte related data (such as, for example, data corresponding to monitored analyte level and/or monitored temperature data, and/or stored historical analyte related data) when on body electronics 110 receives a command or request signal from display device 120. In certain embodiments, on body electronics 110 may be configured to at least periodically broadcast real time data associated with monitored analyte level which is received by display device 120 when display device 120 is within communication range of the data broadcast from on body electronics 110, i.e., it does not need a command or request from a display device to send information.

For example, display device 120 may be configured to transmit one or more commands to on body electronics 110 to initiate data transfer, and in response, on body electronics 110 may be configured to wirelessly transmit stored analyte related data collected during the monitoring time period to display device 120. Display device 120 may in turn be connected to a remote terminal 170 such as a personal computer and functions as a data conduit to transfer the stored analyte level information from the on body electronics 110 to remote terminal 170. In certain embodiments, the received data from the on body electronics 110 may be stored (permanently or temporarily) in one or more memory of the display device 120. In certain other embodiments, display device 120 is configured as a data conduit to pass the data received from on body electronics 110 to remote terminal 170 that is connected to display device 120.

Referring still to FIG. 1B, also shown in analyte monitoring system 100 are data processing module 160 and remote terminal 170. Remote terminal 170 may include a personal computer, a server terminal a laptop computer or other suitable data processing devices including software for data management and analysis and communication with the components in the analyte monitoring system 100. For example, remote terminal 170 may be connected to a local area network (LAN), a wide area network (WAN), or other data network for uni-directional or bi-directional data communication between remote terminal 170 and display device 120 and/or data processing module 160.

Remote terminal 170 in certain embodiments may include one or more computer terminals located at a physician's office or a hospital. For example, remote terminal 170 may be located at a location other than the location of display device 120. Remote terminal 170 and display device 120 could be in different rooms or different buildings. Remote terminal 170 and display device 120 could be at least about one mile apart, e.g., at least about 10 miles apart, e.g., at least about 100 miles apart. For example, remote terminal 170 could be in the same city as display device 120, remote terminal 170 could be in a different city than display device 120, remote terminal 170 could be in the same state as display device 120, remote terminal 170 could be in a different state than display device 120, remote terminal 170 could be in the same country as display device 120, or remote terminal 170 could be in a different country than display device 120, for example.

In certain embodiments, a separate, optional data communication/processing device such as data processing module 160 may be provided in analyte monitoring system 100. Data processing module 160 may include components to communicate using one or more wireless communication protocols such as, for example, but not limited to, infrared (IR) protocol, Bluetooth® protocol, Zigbee® protocol, and 802.11 wireless LAN protocol. Additional description of communication protocols including those based on Bluetooth® protocol and/or Zigbee® protocol can be found in U.S. Patent Publication No. 2006/0193375 incorporated herein by reference for all purposes. Data processing module 160 may further include communication ports, drivers or connectors to establish wired communication with one or more of display device 120, on body electronics 110, or remote terminal 170 including, for example, but not limited to USB connector and/or USB port, Ethernet connector and/or port, FireWire connector and/or port, or RS-232 port and/or connector.

In certain embodiments, data processing module 160 is programmed to transmit a polling or query signal to on body electronics 110 at a predetermined time interval (e.g., once every minute, once every five minutes, or the like), and in response, receive the monitored analyte level information from on body electronics 110. Data processing module 160 stores in its memory the received analyte level information, and/or relays or retransmits the received information to another device such as display device 120. More specifically in certain embodiments, data processing module 160 may be configured as a data relay device to retransmit or pass through the received analyte level data from on body electronics 110 to display device 120 or a remote terminal (for example, over a data network such as a cellular or WiFi data network) or both.

In certain embodiments, on body electronics 110 and data processing module 160 may be positioned on the skin surface of the user within a predetermined distance of each other (for example, about 1-12 inches, or about 1-10 inches, or about 1-7 inches, or about 1-5 inches) such that periodic communication between on body electronics 110 and data processing module 160 is maintained. Alternatively, data processing module 160 may be worn on a belt or clothing item of the user, such that the desired distance for communication between the on body electronics 110 and data processing module 160 for data communication is maintained. In a further aspect, the housing of data processing module 160 may be configured to couple to or engage with on body electronics 110 such that the two devices are combined or integrated as a single assembly and positioned on the skin surface. In further embodiments, data processing module 160 is detachably engaged or connected to on body electronics 110 providing additional modularity such that data processing module 160 may be optionally removed or reattached as desired.

Referring again to FIG. 1B, in certain embodiments, data processing module 160 is programmed to transmit a command or signal to on body electronics 110 at a predetermined time interval such as once every minute, or once every 5 minutes or once every 30 minutes or any other suitable or desired programmable time interval to request analyte related data from on body electronics 110. When data processing module 160 receives the requested analyte related data, it stores the received data. In this manner, analyte monitoring system 100 may be configured to receive the continuously monitored analyte related information at the programmed or programmable time interval, which is stored and/or displayed to the user. The stored data in data processing module 160 may be subsequently provided or transmitted to display device 120, remote terminal 170 or the like for subsequent data analysis such as identifying frequency of periods of glycemic level excursions over the monitored time period, or the frequency of the alarm event occurrence during the monitored time period, for example, to improve therapy related decisions. Using this information, the doctor, healthcare provider or the user may adjust or recommend modification to the diet, daily habits and routines such as exercise, and the like.

In another embodiment, data processing module 160 transmits a command or signal to on body electronics 110 to receive the analyte related data in response to a user activation of a switch provided on data processing module 160 or a user initiated command received from display device 120. In further embodiments, data processing module 160 is configured to transmit a command or signal to on body electronics 110 in response to receiving a user initiated command only after a predetermined time interval has elapsed. For example, in certain embodiments, if the user does not initiate communication within a programmed time period, such as, for example about 5 hours from last communication (or 10 hours from the last communication, or 24 hours from the last communication), the data processing module 160 may be programmed to automatically transmit a request command or signal to on body electronics 110. Alternatively, data processing module 160 may be programmed to activate an alarm to notify the user that a predetermined time period of time has elapsed since the last communication between the data processing module 160 and on body electronics 110. In this manner, users or healthcare providers may program or configure data processing module 160 to provide certain compliance with analyte monitoring regimen, so that frequent determination of analyte levels is maintained or performed by the user.

In certain embodiments, when a programmed or programmable alarm condition is detected (for example, a detected glucose level monitored by analyte sensor 101 that is outside a predetermined acceptable range indicating a physiological condition which requires attention or intervention for medical treatment or analysis (for example, a hypoglycemic condition, a hyperglycemic condition, an impending hyperglycemic condition or an impending hypoglycemic condition), the one or more output indications may be generated by the control logic or processor of the on body electronics 110 and output to the user on a user interface of on body electronics 110 so that corrective action may be timely taken. In addition to or alternatively, if display device 120 is within communication range, the output indications or alarm data may be communicated to display device 120 whose processor, upon detection of the alarm data reception, controls the display 122 to output one or more notification.

In certain embodiments, control logic or microprocessors of on body electronics 110 include software programs to determine future or anticipated analyte levels based on information obtained from analyte sensor 101, e.g., the current analyte level, the rate of change of the analyte level, the acceleration of the analyte level change, and/or analyte trend information determined based on stored monitored analyte data providing a historical trend or direction of analyte level fluctuation as function time during monitored time period. Predictive alarm parameters may be programmed or programmable in display device 120, or the on body electronics 110, or both, and output to the user in advance of anticipating the user's analyte level reaching the future level. This provides the user an opportunity to take timely corrective action.

Information, such as variation or fluctuation of the monitored analyte level as a function of time over the monitored time period providing analyte trend information, for example, may be determined by one or more control logic or microprocessors of display device 120, data processing module 160, and/or remote terminal 170, and/or on body electronics 110. Such information may be displayed as, for example, a graph (such as a line graph) to indicate to the user the current and/or historical and/or and predicted future analyte levels as measured and predicted by the analyte monitoring system 100. Such information may also be displayed as directional arrows (for example, see trend or directional arrow display 131) or other icon(s), e.g., the position of which on the screen relative to a reference point indicated whether the analyte level is increasing or decreasing as well as the acceleration or deceleration of the increase or decrease in analyte level. This information may be utilized by the user to determine any necessary corrective actions to ensure the analyte level remains within an acceptable and/or clinically safe range. Other visual indicators, including colors, flashing, fading, etc., as well as audio indicators including a change in pitch, volume, or tone of an audio output and/or vibratory or other tactile indicators may also be incorporated into the display of trend data as means of notifying the user of the current level and/or direction and/or rate of change of the monitored analyte level. For example, based on a determined rate of glucose change, programmed clinically significant glucose threshold levels (e.g., hyperglycemic and/or hypoglycemic levels), and current analyte level derived by an in vivo analyte sensor, the system 100 may include an algorithm stored on computer readable medium to determine the time it will take to reach a clinically significant level and will output notification in advance of reaching the clinically significant level, e.g., 30 minutes before a clinically significant level is anticipated, and/or 20 minutes, and/or 10 minutes, and/or 5 minutes, and/or 3 minutes, and/or 1 minute, and so on, with outputs increasing in intensity or the like.

Referring again back to FIG. 1B, in certain embodiments, software algorithm(s) for execution by data processing module 160 may be stored in an external memory device such as an SD card, microSD card, compact flash card, XD card, Memory Stick card, Memory Stick Duo card, or USB memory stick/device including executable programs stored in such devices for execution upon connection to the respective one or more of the on body electronics 110, remote terminal 170 or display device 120. In a further aspect, software algorithms for execution by data processing module 160 may be provided to a communication device such as a mobile telephone including, for example, WiFi or Internet enabled smart phones or personal digital assistants (PDAs) as a downloadable application for execution by the downloading communication device.

Examples of smart phones include Windows®, Android®, iPhone® operating system, Palm® WebOS®, Blackberry® operating system, or Symbian® operating system based mobile telephones with data network connectivity functionality for data communication over an internet connection and/or a local area network (LAN). PDAs as described above include, for example, portable electronic devices including one or more microprocessors and data communication capability with a user interface (e.g., display/output unit and/or input unit, and configured for performing data processing, data upload/download over the internet, for example. In such embodiments, remote terminal 170 may be configured to provide the executable application software to the one or more of the communication devices described above when communication between the remote terminal 170 and the devices are established.

In still further embodiments, executable software applications may be provided over-the-air (OTA) as an OTA download such that wired connection to remote terminal 170 is not necessary. For example, executable applications may be automatically downloaded as software download to the communication device, and depending upon the configuration of the communication device, installed on the device for use automatically, or based on user confirmation or acknowledgement on the communication device to execute the installation of the application. The OTA download and installation of software may include software applications and/or routines that are updates or upgrades to the existing functions or features of data processing module 160 and/or display device 120.

Referring back to remote terminal 170 of FIG. 1B, in certain embodiments, new software and/or software updates such as software patches or fixes, firmware updates or software driver upgrades, among others, for display device 120 and/or on body electronics 110 and/or data processing module 160 may be provided by remote terminal 170 when communication between the remote terminal 170 and display device 120 and/or data processing module 160 is established. For example, software upgrades, executable programming changes or modification for on body electronics 110 may be received from remote terminal 170 by one or more of display device 120 or data processing module 160, and thereafter, provided to on body electronics 110 to update its software or programmable functions. For example, in certain embodiments, software received and installed in on body electronics 110 may include software bug fixes, modification to the previously stalled software parameters (modification to analyte related data storage time interval, resetting or adjusting time base or information of on body electronics 110, modification to the transmitted data type, data transmission sequence, or data storage time period, among others). Additional details describing field upgradability of software of portable electronic devices, and data processing are provided in U.S. patent application Ser. Nos. 12/698,124, 12/794,721, now U.S. Pat. No. 8,595,607, Ser. No. 12/699,653, and 12/699,844, and U.S. Provisional Application Nos. 61/359,265, and 61/325,155, the disclosures of which are incorporated by reference herein for all purposes.

Referring to FIGS. 1A and 1B, an analyte monitoring system 100 can generally include, in accordance with one embodiment, an on-body analyte monitoring device, a receiver 120, data processing terminal 170, and secondary receiver unit 106. Generally, analyte sensor 101 operatively contacts an analyte to be monitored in a biological fluid, such as, but not limited to, blood or interstitial fluid, and converts the contacted analyte level into data signals relating to the amount or concentration of the analyte. The data signals are communicated to the on body electronics 110, which is in electrical communication with analyte sensor 101. The electronics unit can be a separate and distinct component, or can be integrated with the analyte sensor to define a single component. The on body electronics 110 processes the data signals (e.g., encodes signals) received from analyte sensor 101 and transmits the processed data signals to receiver 120, e.g., a primary receiver, along a communication link 103. The communication between on body electronics 110 and receiver 120 can be either unidirectional or bidirectional.

In one aspect of the invention, an interconnect is provided to establish electrical communication with a transmitter, transceiver, communications circuit or other electronics. For example, as illustrated in FIG. 2, on-body electronics unit 110 comprises a body including housing 202. The housing includes a top wall connected to a bottom wall by a sidewall. An elongate interconnect 204 can be coupled to the on body electronics 110. The elongate interconnect 204 comprises conductive material disposed at least partially along a body having a first end 212 coupled, e.g., permanently affixed or removably fixed, to housing 202. In one embodiment, the first end 212 can be secured to a printed circuit board 208 disposed in the body of the on body electronics 110. The elongate interconnect can further include a second end 214 engaged to the on body electronics body, for example, the second end 214 in some embodiments, can be engaged to the housing 202, such as slidingly engaged, for example at an end opposite the first end 212. Alternatively, the second end of interconnect 204 may be permanently affixed to the opposite side of housing 202.

As shown in FIG. 2, a length of the elongate interconnect body 204 can be configured to extend laterally from a sidewall of the housing 202. In one embodiment, the elongate interconnect 204 body can include a generally U-shaped configuration along its length. As such, the interconnect can be configured to physically contact an analyte sensor disposed proximate the on body electronics body.

In some embodiments, a conductive contact 206 can be located along a length of the elongate interconnect 204. The contact plate is configured to contact an analyte sensor and establish electrical conductivity between the on body electronics and the analyte sensor. (See FIG. 4). As described, the elongate interconnect comprises conductive material. In one embodiment, the conductive material defines one or more conductive areas along the body of the interconnect. The conductive areas can include one or more conductive contacts and one or more conductive traces disposed between conductive contacts along at least a portion of the length of the elongate interconnect body. Thus, when in direct contact with the electronic circuitry of the on body electronics and/or a sensor, electrical communications can be established.

For example, referring now to FIG. 3, one embodiment of elongate interconnect 204 includes the one or more conductive areas defined by conductive material 302, 306, 308. As shown, conductive traces 302 extend between conductive contacts 306 and 308. In this manner, the elongate interconnect includes a conductive surface attachable to the on body electronics, which can establish electrical communication with the on body electronics during contact.

In some embodiments, the conductive material of elongate interconnect includes conductive traces 302 embedded in a flexible material, such as a flexible strip 304, which generally can be formed from a thermoplastic material. Suitable thermoplastic materials include polyimides such as Apical, Kapton, UPILEX, VTEC PI, Norton TH and Kaptrex. In other embodiments, conductive traces 302 are encapsulated in a flexible sheath. The elongate interconnect can further include conductive films and tapes as described infra.

Suitable elongate interconnects 204 include those depicted in FIGS. 5A-5D. As illustrated, the elongate interconnect can comprise conductive material including conductive cables, including but not limited to high speed ribbon cables, microquick twist ribbon cables, microZip cables, mini probe cables, quick twist cables, ribbonized automation cables, shielded flat ribbon cables, or wide pitch ribbon cables, as illustrated in FIGS. 5A to 5D. In addition, other suitable elongate interconnects include All Flex®, Molex®, Tech-Etch®, and Teknoflex®.

The conductive material associated with the interconnect, as well as the on body electronics and/or analyte sensor, can comprise a non-corroding metal or carbon wire. Suitable conductive materials include, for example, vitreous carbon, graphite, silver, silver-chloride, platinum, palladium, or gold. The conductive material disposed on the component part, e.g., interconnect, sensor, or on body electronics, can comprise a combination of conductive metals, alloys and polymers. In this regard, for example, the electrodes and the conductive traces and/or conductive contacts can be formed from different conductive materials. The conductive material can be applied to the substrate by various techniques including laser ablation, printing, etching, and photolithography. However, any suitable conductive material may be utilized.

Referring back to FIG. 3, conductive contact 306, which is located proximate first end 212, can establish electrical communication with the on body electronics 110, for example, the printed circuit board. The electrical communication in the form of electrical signals can travel towards or from the analyte sensor (not shown) via the conductive traces 302 and conductive contacts 308. Similarly, conductive area 308, located along a length of elongate member 204, allows conductive traces 302 to be in electrical communication with conductive contact 206 (not shown) such that a closed circuit is established between the analyte sensor, interconnect and on body electronics.

In one embodiment, on body electronics 110 includes a temperature sensor. For each sampled signal from analyte sensor 101, the temperature sensor can provide measured temperature information. In another embodiment, on body electronics 110 includes a low-temperature monitor that disables communication from on body electronics 110 if the measured temperature falls below a predefined threshold (e.g., below 5° C.). This is done to protect the on body electronics from over-stressing the energy source of the on body electronics under low-temperature conditions. If the temperature rises above the predefined threshold, the low-temperature monitor enables communication from on body electronics 110.

In accordance with another aspect of the invention, on body electronics 110 includes a low battery voltage monitor that disables the energy source of the on body electronics if the voltage level is too low to reliably transmit communication. The temperature sensor, low-temperature monitor, and the low battery voltage monitor may be controlled via a processor located in on body electronics 110. In a preferred embodiment, the processor is an application specific integrated circuit (ASIC).

In another aspect, as shown in FIG. 4, an on-body analyte monitoring device 100 is provided. The on-body analyte monitoring device includes on body electronics 110 coupled to analyte sensor 402. In one embodiment, the analyte sensor 402 and on body electronics 110 are housed in a mounting unit 404. The mounting unit includes adhesive applied to the bottom surface to attach the on-body unit to a user.

As illustrated in FIG. 4, elongate interconnect conductive contact 206 can be in direct contact with analyte sensor 402 to establish electrical communication between the on body electronics 110 and sensor 402. When analyte sensor 402 is in contact with on body electronics 110, elongate member 204 can be compressed or collapsed and seal 210 forms a protective barrier around the connection from harmful elements (e.g., dust, liquid, dirt) between the on body electronics and sensor. In one embodiment, seal 210 is formed from a flexible polymer.

Seal 210 may be an individual molded component made of a flexible polymer, low durometer silicone, rubber or some other material TPE. In some embodiments, the interconnect extends approximately 1 mm beyond the face of seal 210. When on body electronics 110 is locked into position, elongate interconnect 204 compresses and makes contact with the conductive pads on analyte sensor 402. The seal also compresses to form a barrier around the perimeter of the interconnect/sensor connection. Interconnect 204 may function without the seal, however once liquid or dust got in, the interconnect/sensor interface may be compromised and fail.

In some embodiments, the seal 210 includes an opening to permit direct contact of a conductive contact disposed on the interconnect to the analyte sensor. In this manner, the analyte sensor and the on body electronics can establish electrical conductivity via the closed circuit provided by the interconnect.

In another embodiment, the elongate member 204 returns to its original configuration after analyte sensor 402 is disengaged from on body electronics 110. The signals generated by the analyte sensor relating to the measured analyte levels from biological fluid can be processed by the on body electronics 110 by the electrical contact between sensor 402 and on body electronics via contact plate 206 of interconnect.

The analyte sensor 402 employed in the on-body device, in some embodiments, comprises a substrate, one or more electrodes, a sensing layer and a barrier layer, as described below and disclosed in U.S. Pat. Nos. 6,284,478 and 6,990,366, the disclosures of which are incorporated herein by reference. As the sensor is employed by insertion and/or implantation into a user's body for a period of days, in some embodiments, the substrate is formed from a relatively flexible material to improve comfort for the user and reduce damage to the surrounding tissue of the insertion site, e.g., by reducing relative movement of the sensor with respect to the surrounding tissue.

Suitable materials for a flexible substrate include, for example, non-conducting plastic or polymeric materials and other non-conducting, flexible, deformable materials. Suitable plastic or polymeric materials include thermoplastics such as polycarbonates, polyesters (e.g., Mylar® and polyethylene terephthalate (PET)), polyvinyl chloride (PVC), polyurethanes, polyethers, polyamides, polyimides, or copolymers of these thermoplastics, such as PETG (glycol-modified polyethylene terephthalate). In other embodiments, the sensor includes a relatively rigid substrate. Suitable examples of rigid materials that may be used to form the substrate include poorly conducting ceramics, such as aluminum oxide and silicon dioxide. Further, the substrate can be formed from an insulating material. Suitable insulating materials include polyurethane, teflon (fluorinated polymers), polyethyleneterephthalate (PET, Dacron) or polyimide.

The sensor can include a distal end and a proximal end having different widths. In such embodiments, the distal end of the substrate may have a relatively narrow width. Moreover, sensors intended to be transcutaneously positioned into the tissue of a user's body can be configured to have a narrow distal end or distal point to facilitate the insertion of the sensor. For example, for insertable sensors designed for continuous or periodic monitoring of the analyte during normal activities of the patient, a distal end of the sensor which is to be implanted into the user has a width of 2 mm or less, preferably 1 mm or less, and more preferably 0.5 mm or less.

A plurality of electrodes is disposed near the distal end of the sensor. The electrodes can include a working electrode, counter electrode and reference electrode. Other embodiments, however, can include less or more electrodes. For example, as noted, a two electrode sensor can be utilized. Each of the electrodes is formed from conductive material, for example, a non-corroding metal or carbon wire. Suitable conductive materials include, for example, vitreous carbon, graphite, silver, silver-chloride, platinum, palladium, or gold. The conductive material can be applied to the substrate by various techniques including laser ablation, printing, etching, and photolithography. In one embodiment, each of the electrodes is formed from gold by a laser ablation technique. As further illustrated, the sensor can include conductive traces and extending from the one or more electrodes to respective contacts. In one embodiment, an insulating substrate (e.g., dielectric material) and electrodes can be arranged in a stacked orientation (i.e., insulating substrate disposed between electrodes. Alternatively, the electrodes can be arranged in a side by side orientation, as described in U.S. Pat. No. 6,175,752, the disclosure of which is incorporated herein by reference.

The sensor can include a sensing layer to facilitate the electrolysis of the analyte of interest. For example, the sensing layer can be an immobilized sensing layer comprising a catalyst and an electron transfer agent. Examples of immobilized sensing layers are described in U.S. Pat. Nos. 5,262,035, 5,264,104, 5,264,105, 5,320,725, 5,593,852, and 5,665,222, each of which is incorporated herein by reference. In some embodiments, the sensor can further include a barrier layer to act as a diffusion-limiting barrier to reduce the rate of mass transport of the analyte into the region around the working electrode. Examples of suitable barrier layers are described in U.S. Pat. Nos. 6,990,366 and 6,175,752, each of which is incorporated herein by reference.

In some embodiments, the sensor is a self-powered analyte sensor, which is capable of spontaneously passing a currently directly proportional to analyte concentration in the absence of an external power source. Any exemplary sensor is described in U.S. patent application Ser. No. 12/393,921, filed Feb. 26, 2009, entitled “Self-Powered Analyte Sensor,” which is hereby incorporated by reference in its entirety herein for all purposes.

FIGS. 6, 7A-7B, and 8 illustrate on body electronics including a module interconnect in certain embodiments, with FIGS. 8 and 7A illustrate top perspective views, while FIGS. 7B and 8 illustrating bottom perspective views. Referring to FIGS. 6 and 7A, on body electronics 600 includes modular sensor assembly 604 which includes analyte sensor 710 (see e.g., FIG. 7B), for engageably coupling with electronics component 604. As illustrated, the modular sensor assembly 602 may be configured to interlock or otherwise engage with the electronics component 604. Accordingly, upon engagement of modular sensor assembly 602 and electronics component 604, on body electronics 600 with analyte sensor 710 may be provided.

In certain embodiments, modular sensor assembly 602 may be a molded device, such as for example, formed by injection molding techniques. As illustrated in FIG. 7A, modular sensor assembly 602 includes bottom surface 701 connected to top surface 702 by sidewall 703. As can be seen in the perspective views of FIGS. 7B and 8, in certain embodiments, top surface 702 includes conductive material 714 disposed thereon. Further, top surface 702 may include a vertical surface extending downwardly, which may include conductive material 716 disposed thereon. In certain embodiments, conductive material 716 includes conductive traces and/or conductive contacts.

Still referring to the figures, on body electronics 600 in certain embodiments include modular sensor assembly 602 and electronics component 604 configured for a slidable engagement. As illustrated in FIG. 7A, the bottom of electronics component 604 may include a surface configured to slidably receive modular sensor assembly 602. Further, in certain embodiments, top surface 702 of modular sensor assembly 602 may be configured to define a tongue to interlock with a corresponding groove 704 defined in electronics component 604 to define the shape of on body electronics 600.

Electronics component 604 in certain embodiments may include one or more PCBs including conductive material 708 disposed thereon, such as one or more conductive traces and/or conductive contacts. During engagement of electronics component 604 with modular sensor assembly 602, the conductive material 708 can interface with interconnect conductive material 714. Thus, during engagement, the electronics component 604 and modular sensor assembly 602 establishes electrical communication.

As illustrated in FIG. 7B, modular sensor assembly 602 includes analyte sensor 710 secured or otherwise coupled to a surface of the modular sensor assembly 602. For example, analyte sensor 710 may be coupled to the vertical surface extending from the top surface of the modular sensor assembly 602. In this manner, the vertical surface includes conductive material, such as conductive contacts 804 that connect with the one or more conductive contacts of analyte sensor 710 to establish an electrical communication between analyte sensor 710 and modular sensor assembly 602.

In certain embodiments, as best illustrated in FIGS. 7B and 8, analyte sensor 710 may be mounted to the sidewall of modular sensor assembly 602. In this embodiment, distal portion 710a of analyte sensor 710 is inserted perpendicular to the skin (not shown). In this regard, the bottom surface of the modular sensor assembly 602 includes an aperture 720 (FIG. 7B) to permit the distal portion 710a of analyte sensor 710 to extend from the bottom of on body electronics 600 such that distal portion 710a of analyte sensor 710 may be implanted into the body of a user when in use. In certain embodiments, modular sensor assembly 602 may also include a power source 712, such as a battery. Power source 712 may provide power via conductive traces 714 to the electronics component 604. In this manner, the electronics component 604 may be powered by power source 712 of modular sensor assembly 602 such that the electronics component 604 does not need an internal power source.

The conductive material disposed on the modular sensor assembly 602 and/or the electronics component 604 and analyte sensor 710 may include conductive film, such as, but not limited to, an anisotropic film. Conductive material, such as the conductive film and/or the Zebra style connector, can provide both a mechanical and electrical connection between modular sensor assembly 602 and sensor 710 or electronics component 604. Modular sensor assembly 602, analyte sensor 710, and electronics component 604 may also be bonded together utilizing an adhesive, such as a UV curable adhesive, or a multi-adhesive, such as a silver loaded epoxy can be used. Other adhesives can alternatively be employed.

The sensor and the on body electronics can establish electrical communication by way of the interconnect. In this manner, the one or more electrodes of the analyte sensor generate a signal relative to the analyte levels depicted in the bodily fluid of the user, the conductive traces permit the signal to travel to the conductive contacts of the sensor which is in electrical communication with the conductive material, e.g., conductive contacts 804 of the interconnect. By way of the conductive traces 716 and 802, which establish electrical communication with the on body electronics 600, the signals relative to the analyte levels are communicated to the on body electronics 600. The bottom surface of the on body electronics 600 and/or modular sensor assembly 602 can include an adhesive to attach to the skin of the user. Thus, the interconnect can serve as a mounting unit for the on-body monitoring device to be worn by a user. The on-body analyte monitoring device, as described above, can be employed as a component of an analyte monitoring system, such as the systems illustrated in FIGS. 1A and 1B.

On body electronics 600 may be mounted to the user as one component or separately. For example, with reference to FIG. 7A, the modular sensor assembly 602 may be first mounted on the skin such that the distal portion 710a (not shown) of the sensor 710 is at least partially inserted into the skin. An adhesive (not shown) is used to fix modular sensor assembly 602 to the skin. Subsequently, the electronics component 604 may be attached to modular sensor assembly 602, for example, by sliding the electronics component 604 in the direction of arrow 7A, such that the modular sensor assembly 602 and electronics component 604 are secured together. In some embodiments, the electronics component 604 is mounted first and the modular sensor assembly 602 is mounted subsequently.

In some embodiments, the modular sensor assembly 602 and electronics component 604 are secured together, and then subsequently mounted onto the patient as a single unit 600. Insertion of electronics unit 600 by an inserter, such as inserter 150 (FIG. 1B) is further described as an insertion device, e.g., as described in U.S. patent application Ser. No. 12/698,129 filed on Feb. 1, 2010 and U.S. Provisional Application Nos. 61/238,646, 61/246,825, 61/247,516, 61/249,535, 61/317,243, 61/345,562, and 61/361,374, the disclosures of each of which are incorporated herein by reference for all purposes.

In some embodiments, the analyte monitoring system 100 can include a secondary receiver unit 106 which is operatively coupled to the communication link and configured to receive data transmitted from the on body electronics 110. Moreover, the secondary receiver unit 106 can be configured to communicate with the display unit 120 as well as a data processing terminal 170. The secondary receiver unit 106 may be configured for bi-directional wireless communication with each or one of the display unit 104 and the data processing terminal 170.

In one embodiment, the secondary receiver unit 106 may be configured to include a limited number of functions and features as compared with the display unit 104. As such, the secondary receiver unit 106 may be configured substantially in a smaller compact housing or embodied in a device such as a wrist watch, pager, mobile phone, PDA, for example. Alternatively, the secondary receiver 106 may be configured with the same or substantially similar functionality as the display unit 104. The receiver unit may be configured to be used in conjunction with a docking cradle unit, for example for one or more of the following or other functions: placement by bedside, for re-charging, for data management, for night time monitoring, and/or bi-directional communication device.

Various other modifications and alterations in the structure and method of operation of this invention will be apparent to those skilled in the art without departing from the scope and spirit of the invention. Although the invention has been described in connection with specific preferred embodiments, it should be understood that the invention as claimed should not be unduly limited to such specific embodiments. It is intended that the following claims define the scope of the present invention and that structures and methods within the scope of these claims. Additional detailed description of embodiments of the disclosed subject matter are provided in, but not limited to: U.S. Pat. Nos. 7,299,082; 7,167,818; 7,041,468; 6,942,518; 6,893,545; 6,881,551; 6,773,671; 6,764,581; 6,749,740; 6,746,582; 6,736,957; 6,730,200; 6,676,816; 6,618,934; 6,616,819; 6,600,997; 6,592,745; 6,591,125; 6,560,471; 6,540,891; 6,514,718; 6,514,460; 6,503,381; 6,461,496; 6,377,894; 6,338,790; 6,299,757; 6,284,478; 6,270,455; 6,175,752; 6,161,095; 6,144,837; 6,143,164; 6,121,009; 6,120,676; 6,071,391; 5,918,603; 5,899,855; 5,822,715; 5,820,551; 5,628,890; 5,601,435; 5,593,852; 5,509,410; 5,320,715; 5,264,014; 5,262,305; 5,262,035; 4,711,245; 4,545,382; 5,356,786; 5,543,326; 6,103,033; 6,134,461; 6,143,164; 6,144,837; 6,161,095; 6,579,690; 6,605,200; 6,605,201; 6,618,934; 6,654,625; 6,676,816; 6,730,200; 6,736,957; 6,932,892; U.S. Publication No. 2004/0186365, now U.S. Pat. No. 7,811,231; U.S. Publication No. 2005/0182306, now U.S. Pat. No. 8,771,183; U.S. Publication No. 2006/0025662, now U.S. Pat. No. 7,740,581; U.S. Publication No. 2006/0091006; U.S. Publication No. 2007/0056858, now U.S. Pat. No. 8,298,389; U.S. Publication No. 2007/0068807, now U.S. Pat. No. 7,846,311; U.S. Publication No. 2007/0095661; U.S. Publication No. 2007/0108048, now U.S. Pat. No. 7,918,975; U.S. Publication No. 2007/0199818, now U.S. Pat. No. 7,811,430; U.S. Publication No. 2007/0227911, now U.S. Pat. No. 7,887,682; U.S. Publication No. 2007/0233013; U.S. Publication No. 2008/0066305, now U.S. Pat. No. 7,895,740; U.S. Publication No. 2008/0081977, now U.S. Pat. No. 7,618,369; U.S. Publication No. 2008/0102441, now U.S. Pat. No. 7,822,557; U.S. Publication No. 2008/0148873, now U.S. Pat. No. 7,802,467; U.S. Publication No. 2008/0161666; U.S. Publication No. 2008/0267823; U.S. Publication No. 2009/0054748, now U.S. Pat. No. 7,885,698; U.S. patent application Ser. No. 10/745,878, filed Dec. 26, 2003, now U.S. Pat. No. 7,811,231, and entitled “Continuous Glucose Monitoring System and Methods of Use”, U.S. patent application Ser. No. 12/143,731, filed Jun. 20, 2008, now U.S. Pat. No. 8,597,188, and entitled “Health Management Devices And Methods”; U.S. patent application Ser. No. 12/143,734, filed Jun. 20, 2008, now U.S. Pat. No. 8,617,069, and entitled “Health Monitor”; U.S. Provisional Patent Application No. 61/149,639, filed Feb. 3, 2009, and entitled “Compact On-Body Physiological Monitoring Devices And Methods Thereof”; U.S. Provisional Application No. 61/291,326, filed Dec. 30, 2009, and U.S. Provisional Application No. 61/299,924 filed Jan. 29, 2010; U.S. patent application Ser. No. 11/461,725, now U.S. Pat. No. 7,866,026; U.S. patent application Ser. No. 12/131,012; U.S. patent application Ser. No. 12/242,823, now U.S. Pat. No. 8,219,173; U.S. patent application Ser. No. 12/363,712, now U.S. Pat. No. 8,346,335; U.S. patent application Ser. No. 12/698,124; U.S. patent application Ser. No. 12/698,129; U.S. patent application Ser. No. 12/714,439; U.S. patent application Ser. No. 12/794,721, now U.S. Pat. No. 8,595,607; U.S. patent application Ser. No. 12/842,013; U.S. Patent Application No. 61/238,646; U.S. Patent Application No. 61/345,562; U.S. Patent Application No. 61/361,374; and elsewhere, the disclosures of each are incorporated by reference in their entirety herein for all purposes.

Claims

1. An on-body glucose monitoring device, comprising: a housing having a top surface and an opposing bottom surface, the housing defining an interior of the on-body glucose monitoring device;a processor and a printed circuit board disposed within the interior;a glucose sensor, comprising: a proximal portion disposed within the interior; anda distal portion extending from the housing and configured to be in fluid contact with a bodily fluid of a user,wherein the distal portion includes a plurality of electrodes, andwherein the proximal portion includes a plurality of conductive contacts electrically coupled with the plurality of electrodes; andan interconnect disposed within the interior and comprising a plurality of rows of conductive material on a surface of the interconnect, wherein the plurality of rows of conductive material is configured to conduct an electrical signal in a first direction along the interconnect and not conduct the electrical signal in a second direction along the interconnect, wherein the second direction is transverse to the first direction, andwherein the plurality of rows of conductive material is further configured to establish electrical communication between the plurality of conductive contacts of the glucose sensor and the printed circuit board.
2. The on-body glucose monitoring device of claim 1, wherein the plurality of conductive contacts is electrically coupled with the plurality of electrodes by a plurality of conductive traces extending from the plurality of electrodes to the plurality of conductive contacts.
3. The on-body glucose monitoring device of claim 1, wherein the plurality of rows of conductive material is configured to transfer a signal indicative of a glucose level in the bodily fluid of the user from the plurality of electrodes to the printed circuit board.
4. The on-body glucose monitoring device of claim 1, wherein the plurality of electrodes comprises three electrodes.
5. The on-body glucose monitoring device of claim 1, wherein the plurality of rows of conductive material comprises a non-corroding metal or carbon wire.
6. The on-body glucose monitoring device of claim 1, wherein the plurality of rows of conductive material comprises vitreous carbon, graphite, silver, silver-chloride, platinum, palladium, or gold.
7. The on-body glucose monitoring device of claim 1, wherein the plurality of rows of conductive material comprises a combination of conductive metals, alloys and polymers.
8. The on-body glucose monitoring device of claim 1, wherein the plurality of rows of conductive material are formed from different conductive materials.
9. The on-body glucose monitoring device of claim 1, wherein the plurality of rows of conductive material is applied to the interconnect using one or more of laser ablation, printing, etching, and photolithography.
10. The on-body glucose monitoring device of claim 1, wherein the plurality of electrodes includes a working electrode comprising a glucose-responsive enzyme and a mediator, wherein at least one of the glucose-responsive enzyme and the mediator is chemically bonded to a polymer disposed on the working electrode, and wherein at least one of the glucose-responsive enzyme and the mediator is crosslinked with the polymer.
11. The on-body glucose monitoring device of claim 1, further comprising a data communication component disposed within the interior and coupled with the processor and the printed circuit board, the data communication component configured to wirelessly communicate data indicative of a glucose level sensed by the glucose sensor to a remote location.
12. The on-body glucose monitoring device of claim 1, wherein the plurality of rows of conductive material are spaced along a first dimension of the interconnect.
13. The on-body glucose monitoring device of claim 12, wherein the first dimension is a length of the interconnect.
14. The on-body glucose monitoring device of claim 1, wherein the first direction comprises a direction across a width of the interconnect.
15. A system for measurement of a glucose level, comprising: an on-body glucose monitoring device comprising: a housing having a top surface and an opposing bottom surface, the housing defining an interior of the on-body glucose monitoring device;a processor and a printed circuit board disposed within the interior;a glucose sensor, comprising: a proximal portion disposed within the interior; anda distal portion extending from the housing and configured to be in fluid contact with a bodily fluid of a user,wherein the distal portion includes a plurality of electrodes, andwherein the proximal portion includes a plurality of conductive contacts electrically coupled to the plurality of electrodes; andan interconnect disposed within the interior and comprising a plurality of rows of conductive material on a surface of the interconnect, wherein the plurality of rows of conductive material is configured to conduct an electrical signal in a first direction along the interconnect and not conduct the electrical signal in a second direction along the interconnect, wherein the second direction is transverse to the first direction, andwherein the plurality of rows of conductive material is further configured to establish electrical communication between the glucose sensor and the printed circuit board; andan inserter configured to releasably carry the on-body glucose monitoring device prior to use and to transcutaneously position the distal portion of the glucose sensor in fluid contact with the bodily fluid of the user.
16. The system of claim 15, wherein the plurality of conductive contacts is electrically coupled with the plurality of electrodes by a plurality of conductive traces extending from the plurality of electrodes to the plurality of conductive contacts.
17. The system of claim 15, wherein the on-body glucose monitoring device is sealed within the inserter prior to use.
18. The system of claim 15, wherein the plurality of rows of conductive material is configured to transfer a signal indicative of a glucose level in the bodily fluid of the user from the plurality of electrodes to the printed circuit board.
19. The system of claim 15, wherein the plurality of electrodes comprises three electrodes.
20. The system of claim 15, wherein the plurality of rows of conductive material comprises a non-corroding metal or carbon wire.
21. The system of claim 15, wherein the plurality of rows of conductive material comprises vitreous carbon, graphite, silver, silver-chloride, platinum, palladium, or gold.
22. The system of claim 15, wherein the plurality of rows of conductive material comprises a combination of conductive metals, alloys and polymers.
23. The system of claim 15, wherein the plurality of rows of conductive material are formed from different conductive materials.
24. The system of claim 15, wherein the plurality of rows of conductive material is applied to the interconnect using one or more of laser ablation, printing, etching, and photolithography.
25. The system of claim 15, wherein the plurality of electrodes includes a working electrode comprising a glucose-responsive enzyme and a mediator, wherein at least one of the glucose-responsive enzyme and the mediator is chemically bonded to a polymer disposed on the working electrode, and wherein at least one of the glucose-responsive enzyme and the mediator is crosslinked with the polymer.
26. The system of claim 15, further comprising a data communication component disposed within the interior and coupled with the processor and the printed circuit board, the data communication component configured to wirelessly communicate data indicative of a glucose level sensed by the glucose sensor to a remote location.
27. The system of claim 15, wherein the plurality of rows of conductive material are spaced along a first dimension of the interconnect.
28. The on-system of claim 27, wherein the first dimension is a length of the interconnect.
29. The system of claim 15, wherein the first direction comprises a direction across a width of the interconnect.

RELATED APPLICATIONS

The present application is a continuation of U.S. patent application Ser. No. 16/941,717, filed Jul. 29, 2020, which is a continuation of U.S. patent application Ser. No. 15/674,439, filed Aug. 10, 2017, now U.S. Pat. No. 10,765,351, which is a continuation of U.S. patent application Ser. No. 15/140,309, filed Apr. 27, 2016, now U.S. Pat. No. 9,750,444, which is a continuation of U.S. patent application Ser. No. 12/895,015, filed Sep. 30, 2010, now U.S. Pat. No. 9,351,669, which claims the benefit of U.S. Provisional Application No. 61/247,516, filed Sep. 30, 2009, all of which are incorporated herein by reference in their entireties for all purposes.

US Referenced Citations (1449)

Number	Name	Date	Kind
3211001	Petit	Oct 1965	A
3260656	Ross, Jr.	Jul 1966	A
3653841	Klein	Apr 1972	A
3719564	Lilly et al.	Mar 1973	A
3776832	Oswin et al.	Dec 1973	A
3837339	Aisenberg et al.	Sep 1974	A
3926760	Allen et al.	Dec 1975	A
3949388	Fuller	Apr 1976	A
3972320	Kalman	Aug 1976	A
3979274	Newman	Sep 1976	A
4008717	Kowarski	Feb 1977	A
4016866	Lawton	Apr 1977	A
4036749	Anderson	Jul 1977	A
4055175	Clemens et al.	Oct 1977	A
4059406	Fleet	Nov 1977	A
4076596	Connery et al.	Feb 1978	A
4098574	Dappen	Jul 1978	A
4100048	Pompei et al.	Jul 1978	A
4120292	LeBlanc, Jr. et al.	Oct 1978	A
4129128	McFarlane	Dec 1978	A
4151845	Clemens	May 1979	A
4168205	Danninger et al.	Sep 1979	A
4172770	Semersky et al.	Oct 1979	A
4178916	McNamara	Dec 1979	A
4206755	Klein	Jun 1980	A
4224125	Nakamura et al.	Sep 1980	A
4240438	Updike et al.	Dec 1980	A
4245634	Albisser et al.	Jan 1981	A
4247297	Berti et al.	Jan 1981	A
4294258	Bernard	Oct 1981	A
4327725	Cortese et al.	May 1982	A
4340458	Lerner et al.	Jul 1982	A
4344438	Schultz	Aug 1982	A
4349728	Phillips et al.	Sep 1982	A
4352960	Dormer et al.	Oct 1982	A
4356074	Johnson	Oct 1982	A
4365637	Johnson	Dec 1982	A
4366033	Richter et al.	Dec 1982	A
4373527	Fischell	Feb 1983	A
4375399	Havas et al.	Mar 1983	A
4384586	Christiansen	May 1983	A
4390621	Bauer	Jun 1983	A
4401122	Clark, Jr.	Aug 1983	A
4404066	Johnson	Sep 1983	A
4418148	Oberhardt	Nov 1983	A
4425920	Bourland et al.	Jan 1984	A
4427770	Chen et al.	Jan 1984	A
4431004	Bessman et al.	Feb 1984	A
4436094	Cerami	Mar 1984	A
4440175	Wilkins	Apr 1984	A
4450842	Zick et al.	May 1984	A
4458686	Clark	Jul 1984	A
4461691	Frank	Jul 1984	A
4469110	Slama	Sep 1984	A
4477314	Richter et al.	Oct 1984	A
4478976	Goertz et al.	Oct 1984	A
4484987	Gough	Nov 1984	A
4494950	Fischell	Jan 1985	A
4509531	Ward	Apr 1985	A
4522690	Venkatasetty	Jun 1985	A
4524114	Samuels et al.	Jun 1985	A
4526661	Steckhan	Jul 1985	A
4527240	Kvitash	Jul 1985	A
4534356	Papadakis	Aug 1985	A
4538616	Rogoff	Sep 1985	A
4543955	Schroeppel	Oct 1985	A
4545382	Higgins et al.	Oct 1985	A
4552840	Riffer	Nov 1985	A
4560534	Kung et al.	Dec 1985	A
4571292	Liu et al.	Feb 1986	A
4573994	Fischell et al.	Mar 1986	A
4581336	Malloy et al.	Apr 1986	A
4595011	Phillips	Jun 1986	A
4619754	Niki et al.	Oct 1986	A
4619793	Lee	Oct 1986	A
4627445	Garcia et al.	Dec 1986	A
4627842	Katz	Dec 1986	A
4627908	Miller	Dec 1986	A
4633878	Bombardieri	Jan 1987	A
4637403	Garcia et al.	Jan 1987	A
4650547	Gough	Mar 1987	A
4654197	Lilja et al.	Mar 1987	A
4655880	Liu	Apr 1987	A
4655885	Hill et al.	Apr 1987	A
4671288	Gough	Jun 1987	A
4679562	Luksha	Jul 1987	A
4680268	Clark, Jr.	Jul 1987	A
4682602	Probaska	Jul 1987	A
4684463	Williams	Aug 1987	A
4684537	Graetzel et al.	Aug 1987	A
4685466	Rau	Aug 1987	A
4698057	Joishy	Oct 1987	A
4703756	Gough et al.	Nov 1987	A
4711245	Higgins et al.	Dec 1987	A
4711247	Fishman	Dec 1987	A
4717673	Wrighton et al.	Jan 1988	A
4721601	Wrighton et al.	Jan 1988	A
4721677	Clark, Jr.	Jan 1988	A
4726378	Kaplan	Feb 1988	A
4726716	McGuire	Feb 1988	A
4729672	Takagi	Mar 1988	A
4731726	Allen, III	Mar 1988	A
4749985	Corsberg	Jun 1988	A
4755173	Konopka	Jul 1988	A
4757022	Shults et al.	Jul 1988	A
4758323	Davis et al.	Jul 1988	A
4759371	Franetzki	Jul 1988	A
4759828	Young et al.	Jul 1988	A
4764416	Ueyama et al.	Aug 1988	A
4776944	Janata et al.	Oct 1988	A
4777953	Ash et al.	Oct 1988	A
4779618	Mund et al.	Oct 1988	A
4784736	Lonsdale et al.	Nov 1988	A
4795707	Niiyama et al.	Jan 1989	A
4796634	Huntsman et al.	Jan 1989	A
4805624	Yao et al.	Feb 1989	A
4813424	Wilkins	Mar 1989	A
4815469	Cohen et al.	Mar 1989	A
4820399	Senda et al.	Apr 1989	A
4822337	Newhouse et al.	Apr 1989	A
4830959	McNeil et al.	May 1989	A
4832797	Vadgama et al.	May 1989	A
RE32947	Dormer et al.	Jun 1989	E
4840893	Hill et al.	Jun 1989	A
4848351	Finch	Jul 1989	A
4854322	Ash et al.	Aug 1989	A
4865038	Rich et al.	Sep 1989	A
4871351	Feingold	Oct 1989	A
4871440	Nagata et al.	Oct 1989	A
4874500	Madou et al.	Oct 1989	A
4890620	Gough	Jan 1990	A
4894137	Takizawa et al.	Jan 1990	A
4895147	Bodicky et al.	Jan 1990	A
4897162	Lewandowski et al.	Jan 1990	A
4897173	Nankai et al.	Jan 1990	A
4909908	Ross et al.	Mar 1990	A
4911794	Parce et al.	Mar 1990	A
4917800	Lonsdale et al.	Apr 1990	A
4919141	Zier et al.	Apr 1990	A
4919767	Vadgama et al.	Apr 1990	A
4921199	Villaveces	May 1990	A
4923586	Katayama et al.	May 1990	A
4925268	Iyer et al.	May 1990	A
4927516	Yamaguchi et al.	May 1990	A
4934369	Maxwell	Jun 1990	A
4935105	Churchhouse	Jun 1990	A
4935345	Guilbeau et al.	Jun 1990	A
4938860	Wogoman	Jul 1990	A
4944299	Silvian	Jul 1990	A
4950378	Nagata	Jul 1990	A
4953552	DeMarzo	Sep 1990	A
4954129	Giuliano	Sep 1990	A
4969468	Byers et al.	Nov 1990	A
4970145	Bennetto et al.	Nov 1990	A
4974929	Curry	Dec 1990	A
4986271	Wilkins	Jan 1991	A
4988341	Columbus et al.	Jan 1991	A
4994167	Shults et al.	Feb 1991	A
4995402	Smith et al.	Feb 1991	A
5000180	Kuypers et al.	Mar 1991	A
5001054	Wagner	Mar 1991	A
5013161	Zaragoza et al.	May 1991	A
5019974	Beckers	May 1991	A
5035860	Kleingeld et al.	Jul 1991	A
5036860	Leigh et al.	Aug 1991	A
5047044	Smith et al.	Sep 1991	A
5050612	Matsumura	Sep 1991	A
5055171	Peck	Oct 1991	A
5058592	Whisler	Oct 1991	A
5070535	Hochmair et al.	Dec 1991	A
5082550	Rishpon et al.	Jan 1992	A
5082786	Nakamoto	Jan 1992	A
5089112	Skotheim et al.	Feb 1992	A
5095904	Seligman et al.	Mar 1992	A
5101814	Palti	Apr 1992	A
5106365	Hernandez	Apr 1992	A
5108564	Szuminsky et al.	Apr 1992	A
5108889	Smith et al.	Apr 1992	A
5109850	Blanco et al.	May 1992	A
5120420	Nankai et al.	May 1992	A
5122925	Inpyn	Jun 1992	A
5126034	Carter et al.	Jun 1992	A
5133856	Yamaguchi et al.	Jul 1992	A
5135003	Souma	Aug 1992	A
5140985	Schroeder et al.	Aug 1992	A
5141868	Shanks et al.	Aug 1992	A
5161532	Joseph	Nov 1992	A
5165407	Wilson et al.	Nov 1992	A
5174291	Schoonen et al.	Dec 1992	A
5190041	Palti	Mar 1993	A
5192416	Wang et al.	Mar 1993	A
5198367	Aizawa et al.	Mar 1993	A
5202261	Musho et al.	Apr 1993	A
5205920	Oyama et al.	Apr 1993	A
5208154	Weaver et al.	May 1993	A
5209229	Gilli	May 1993	A
5217595	Smith et al.	Jun 1993	A
5229282	Yoshioka et al.	Jul 1993	A
5234835	Nestor et al.	Aug 1993	A
5238729	Debe	Aug 1993	A
5246867	Lakowicz et al.	Sep 1993	A
5250439	Musho et al.	Oct 1993	A
5262035	Gregg et al.	Nov 1993	A
5262305	Heller et al.	Nov 1993	A
5264103	Yoshioka et al.	Nov 1993	A
5264104	Gregg et al.	Nov 1993	A
5264105	Gregg et al.	Nov 1993	A
5264106	McAleer et al.	Nov 1993	A
5271815	Wong	Dec 1993	A
5279294	Anderson et al.	Jan 1994	A
5284156	Schramm et al.	Feb 1994	A
5285792	Sjoquist et al.	Feb 1994	A
5286362	Hoenes et al.	Feb 1994	A
5286364	Yacynch et al.	Feb 1994	A
5288636	Pollmann et al.	Feb 1994	A
5293546	Tadros et al.	Mar 1994	A
5293877	O'Hara et al.	Mar 1994	A
5299571	Mastrototaro	Apr 1994	A
5320098	Davidson	Jun 1994	A
5320725	Gregg et al.	Jun 1994	A
5322063	Allen et al.	Jun 1994	A
5337747	Neftel	Aug 1994	A
5340722	Wolfbeis et al.	Aug 1994	A
5342789	Chick et al.	Aug 1994	A
5352348	Young et al.	Oct 1994	A
5356786	Heller et al.	Oct 1994	A
5360404	Novacek et al.	Nov 1994	A
5368028	Palti	Nov 1994	A
5372133	Hogen et al.	Dec 1994	A
5372427	Padovani et al.	Dec 1994	A
5376251	Kaneko et al.	Dec 1994	A
5378628	Gratzel et al.	Jan 1995	A
5379238	Stark	Jan 1995	A
5387327	Khan	Feb 1995	A
5390670	Centa et al.	Feb 1995	A
5390671	Lord et al.	Feb 1995	A
5391250	Cheney, II et al.	Feb 1995	A
5395504	Saurer et al.	Mar 1995	A
5400782	Beaubiah et al.	Mar 1995	A
5408999	Singh et al.	Apr 1995	A
5411647	Johnson et al.	May 1995	A
5425361	Fenzlein et al.	Jun 1995	A
5431160	Wilkins	Jul 1995	A
5431921	Thombre	Jul 1995	A
5437999	Diebold et al.	Aug 1995	A
5462645	Albery et al.	Oct 1995	A
5469846	Khan	Nov 1995	A
5472317	Field et al.	Dec 1995	A
5489414	Schreiber et al.	Feb 1996	A
5491474	Suni et al.	Feb 1996	A
5494562	Maley et al.	Feb 1996	A
5496453	Uenoyama et al.	Mar 1996	A
5497772	Schulman et al.	Mar 1996	A
5507288	Bocker et al.	Apr 1996	A
5509410	Hill et al.	Apr 1996	A
5514718	Lewis et al.	May 1996	A
5531878	Vadgama et al.	Jul 1996	A
5533977	Matcalf et al.	Jul 1996	A
5545191	Mann et al.	Aug 1996	A
5551427	Altman	Sep 1996	A
5560357	Faupel et al.	Oct 1996	A
5562713	Silvian	Oct 1996	A
5565085	Ikeda et al.	Oct 1996	A
5567302	Song et al.	Oct 1996	A
5568806	Cheney, II et al.	Oct 1996	A
5569186	Lord et al.	Oct 1996	A
5575563	Chiu et al.	Nov 1996	A
5582184	Erickson et al.	Dec 1996	A
5582697	Ikeda et al.	Dec 1996	A
5582698	Flaherty et al.	Dec 1996	A
5584813	Livingston et al.	Dec 1996	A
5586553	Halili et al.	Dec 1996	A
5589326	Deng et al.	Dec 1996	A
5593852	Heller et al.	Jan 1997	A
5596150	Arndt et al.	Jan 1997	A
5601435	Quy	Feb 1997	A
5609575	Larson et al.	Mar 1997	A
5617851	Lipkovker	Apr 1997	A
5628310	Rao et al.	May 1997	A
5628890	Carter et al.	May 1997	A
5632557	Simons	May 1997	A
5651869	Yoshioka et al.	Jul 1997	A
5653239	Pompei et al.	Aug 1997	A
5660163	Schulman et al.	Aug 1997	A
5665222	Heller et al.	Sep 1997	A
5670031	Hintsche et al.	Sep 1997	A
5680858	Hansen et al.	Oct 1997	A
5682233	Brinda	Oct 1997	A
5695623	Sakoda et al.	Dec 1997	A
5708247	McAleer et al.	Jan 1998	A
5711001	Bussan et al.	Jan 1998	A
5711861	Ward et al.	Jan 1998	A
5711862	Sakoda et al.	Jan 1998	A
5741211	Iliff	Jan 1998	A
5733044	Rose et al.	Mar 1998	A
D393313	Meisner et al.	Apr 1998	S
5735285	Albert et al.	Apr 1998	A
5749656	Boehm et al.	May 1998	A
5766131	Kondo et al.	Jun 1998	A
5771001	Cobb	Jun 1998	A
5772586	Heinonen et al.	Jun 1998	A
5779665	Mastrototaro et al.	Jul 1998	A
5791344	Schulman et al.	Aug 1998	A
5800420	Gross et al.	Sep 1998	A
5807375	Gross et al.	Sep 1998	A
5814020	Gross	Sep 1998	A
5820551	Hill et al.	Oct 1998	A
5820622	Gross et al.	Oct 1998	A
5822715	Worthington et al.	Oct 1998	A
5827184	Netherly et al.	Oct 1998	A
5840020	Heinonen et al.	Nov 1998	A
5842983	Abel et al.	Dec 1998	A
5851197	Marano et al.	Dec 1998	A
5858001	Tsals et al.	Jan 1999	A
5865804	Bachynsky	Feb 1999	A
5885211	Eppstein et al.	Mar 1999	A
5899855	Brown	May 1999	A
5924979	Sedlow et al.	Jul 1999	A
5925021	Castellano et al.	Jul 1999	A
5931868	Gross et al.	Aug 1999	A
5938679	Freeman et al.	Aug 1999	A
5948006	Mann	Sep 1999	A
5951521	Mastrototaro et al.	Sep 1999	A
5951582	Thorne et al.	Sep 1999	A
5954643	Van Antwerp et al.	Sep 1999	A
5954685	Tierney	Sep 1999	A
5957854	Besson et al.	Sep 1999	A
5961451	Reber et al.	Oct 1999	A
5964993	Blubaugh et al.	Oct 1999	A
5965380	Heller et al.	Oct 1999	A
5971922	Arita et al.	Oct 1999	A
5972199	Heller et al.	Oct 1999	A
5987353	Khatchatrian et al.	Nov 1999	A
5993411	Choi	Nov 1999	A
5995860	Sun et al.	Nov 1999	A
5997501	Gross et al.	Dec 1999	A
6001067	Shults et al.	Dec 1999	A
6004278	Botich et al.	Dec 1999	A
6022368	Gavronsky et al.	Feb 2000	A
6024699	Surwit et al.	Feb 2000	A
6026321	Miyata et al.	Feb 2000	A
6027459	Sham et al.	Feb 2000	A
6068399	Tseng	Mar 2000	A
6049727	Crothall	Apr 2000	A
6056718	Funderburk et al.	May 2000	A
6083710	Heller et al.	Jul 2000	A
6088608	Schulman et al.	Jul 2000	A
6091975	Daddona et al.	Jul 2000	A
6091976	Pfeiffer et al.	Jul 2000	A
6093172	Funderburk et al.	Jul 2000	A
6103033	Say et al.	Aug 2000	A
6117290	Say et al.	Sep 2000	A
6119028	Schulman et al.	Sep 2000	A
6120676	Heller et al.	Sep 2000	A
6121009	Heller et al.	Sep 2000	A
6121611	Lindsay et al.	Sep 2000	A
6122351	Schlueter, Jr. et al.	Sep 2000	A
6134461	Say et al.	Oct 2000	A
6143164	Heller et al.	Nov 2000	A
6159147	Lichter et al.	Dec 2000	A
6162611	Heller et al.	Dec 2000	A
6175752	Say et al.	Jan 2001	B1
6186982	Gross et al.	Feb 2001	B1
6200265	Walsh et al.	Mar 2001	B1
6212416	Ward et al.	Apr 2001	B1
6219574	Cormier et al.	Apr 2001	B1
6248067	Causey, III et al.	Jun 2001	B1
6254536	DeVito	Jul 2001	B1
6254586	Mann et al.	Jul 2001	B1
6275717	Gross et al.	Aug 2001	B1
6283761	Joao	Sep 2001	B1
6283982	Levaughn et al.	Sep 2001	B1
6284478	Heller et al.	Sep 2001	B1
6293925	Safabash et al.	Sep 2001	B1
6295506	Heinonen et al.	Sep 2001	B1
6302866	Marggi	Oct 2001	B1
6306104	Cunningham et al.	Oct 2001	B1
6309884	Cooper et al.	Oct 2001	B1
6329161	Heller et al.	Dec 2001	B1
6331244	Lewis et al.	Dec 2001	B1
6338790	Feldman et al.	Jan 2002	B1
6348640	Navot et al.	Feb 2002	B1
6359444	Grimes	Mar 2002	B1
6360888	McIvor et al.	Mar 2002	B1
6366794	Moussy et al.	Apr 2002	B1
6368141	Van Antwerp et al.	Apr 2002	B1
6368274	Van Antwerp et al.	Apr 2002	B1
6377828	Chaiken et al.	Apr 2002	B1
6379301	Worthington et al.	Apr 2002	B1
6409740	Kuhr et al.	Jun 2002	B1
6418332	Mastrototaro et al.	Jul 2002	B1
6424847	Mastrototaro et al.	Jul 2002	B1
6427088	Bowman, IV et al.	Jul 2002	B1
6433743	Massy et al.	Aug 2002	B1
6435017	Nowicki, Jr. et al.	Aug 2002	B1
6437679	Rogues	Aug 2002	B1
6440068	Brown et al.	Aug 2002	B1
6445374	Albert et al.	Sep 2002	B2
6478736	Mault	Nov 2002	B1
6482176	Wich	Nov 2002	B1
6484045	Holker et al.	Nov 2002	B1
6484046	Say et al.	Nov 2002	B1
6514718	Heller et al.	Feb 2003	B2
6520326	McIvor et al.	Feb 2003	B2
6522927	Bishay et al.	Feb 2003	B1
6551494	Heller et al.	Apr 2003	B1
6551496	Moles et al.	Apr 2003	B1
6554795	Lam et al.	Apr 2003	B2
6558320	Causey, III et al.	May 2003	B1
6558321	Burd et al.	May 2003	B1
6560471	Heller et al.	May 2003	B1
6561978	Conn et al.	May 2003	B1
6562001	Lebel et al.	May 2003	B2
6564105	Starkweather et al.	May 2003	B2
6565509	Say et al.	May 2003	B1
6571128	Lebel et al.	May 2003	B2
6572566	Effenhauser	Jun 2003	B2
6576101	Heller et al.	Jun 2003	B1
6577899	Lebel et al.	Jun 2003	B2
6579690	Bonnecaze et al.	Jun 2003	B1
6585644	Lebel et al.	Jul 2003	B2
6589229	Connelly et al.	Jul 2003	B1
6591125	Buse et al.	Jul 2003	B1
6595919	Berner et al.	Jul 2003	B2
6605200	Mao et al.	Aug 2003	B1
6605201	Mao et al.	Aug 2003	B1
6607509	Bobroff et al.	Aug 2003	B2
6610012	Mault	Aug 2003	B2
6633772	Ford et al.	Oct 2003	B2
6635014	Starkweather et al.	Oct 2003	B2
6648821	Lebel et al.	Nov 2003	B2
6654625	Say et al.	Nov 2003	B1
6659948	Lebel et al.	Dec 2003	B2
6668196	Villegas et al.	Dec 2003	B1
6676290	Lu	Jan 2004	B1
6687546	Lebel et al.	Feb 2004	B2
6689056	Kilcoyne et al.	Feb 2004	B1
6694191	Starkweather et al.	Feb 2004	B2
6695860	Ward et al.	Feb 2004	B1
6702857	Brauker et al.	Mar 2004	B2
6733446	Lebel et al.	May 2004	B2
6740075	Lebel et al.	May 2004	B2
6741877	Shults et al.	May 2004	B1
6746582	Heller et al.	Jun 2004	B2
6758810	Lebel et al.	Jul 2004	B2
6770030	Schaupp et al.	Aug 2004	B1
6790178	Mault et al.	Sep 2004	B1
6809653	Mann et al.	Oct 2004	B1
6810290	Lebel et al.	Oct 2004	B2
6811533	Lebel et al.	Nov 2004	B2
6811534	Bowman, IV et al.	Nov 2004	B2
6813519	Lebel et al.	Nov 2004	B2
6830551	Uchigaki et al.	Dec 2004	B1
6837858	Cunningham et al.	Jan 2005	B2
6837988	Leong et al.	Jan 2005	B2
6849052	Ughigaki et al.	Feb 2005	B2
6854882	Chen	Feb 2005	B2
6862465	Shults et al.	Mar 2005	B2
6873268	Lebel et al.	Mar 2005	B2
6881551	Heller et al.	Apr 2005	B2
6892085	McIvor et al.	May 2005	B2
6895265	Silver	May 2005	B2
6931327	Goode, Jr. et al.	Aug 2005	B2
6932894	Mao et al.	Aug 2005	B2
6936006	Sabra	Aug 2005	B2
6942518	Liamos et al.	Sep 2005	B2
6950708	Bowman, IV et al.	Sep 2005	B2
6958705	Lebel et al.	Oct 2005	B2
6959211	Rule et al.	Oct 2005	B2
6968294	Gutta et al.	Nov 2005	B2
6971274	Olin	Dec 2005	B2
6971999	Py et al.	Dec 2005	B2
6974437	Lebel et al.	Dec 2005	B2
6990366	Say et al.	Jan 2006	B2
6997907	Safabash et al.	Feb 2006	B2
6998247	Monfre et al.	Feb 2006	B2
7003336	Holker et al.	Feb 2006	B2
7003340	Say et al.	Feb 2006	B2
7003341	Say et al.	Feb 2006	B2
7024245	Lebel et al.	Apr 2006	B2
7025743	Mann et al.	Apr 2006	B2
7041068	Freeman et al.	May 2006	B2
7041468	Drucker et al.	May 2006	B2
7052483	Wojcik	May 2006	B2
7056302	Douglas	Jun 2006	B2
7074307	Simpson et al.	Jul 2006	B2
7081195	Simpson et al.	Jul 2006	B2
7097637	Triplett et al.	Aug 2006	B2
7098803	Mann et al.	Aug 2006	B2
7108778	Simpson et al.	Sep 2006	B2
7110803	Shults et al.	Sep 2006	B2
7113821	Sun et al.	Sep 2006	B1
7134999	Brauker et al.	Nov 2006	B2
7136689	Shults et al.	Nov 2006	B2
7171274	Starkweather et al.	Jan 2007	B2
7190988	Say et al.	Mar 2007	B2
7192450	Brauker et al.	Mar 2007	B2
7198606	Boecker et al.	Apr 2007	B2
7207974	Safabash et al.	Apr 2007	B2
7226978	Tapsak et al.	Jun 2007	B2
7276029	Goode, Jr. et al.	Oct 2007	B2
7278983	Ireland et al.	Oct 2007	B2
7297151	Boecker et al.	Nov 2007	B2
7299082	Feldman et al.	Nov 2007	B2
7310544	Brister et al.	Dec 2007	B2
7318816	Bobroff et al.	Jan 2008	B2
7324012	Mann et al.	Jan 2008	B2
7329239	Safabash et al.	Feb 2008	B2
7335294	Heller et al.	Feb 2008	B2
7340309	Miazga et al.	Mar 2008	B2
7354420	Steil et al.	Apr 2008	B2
7364592	Carr-Brendel et al.	Apr 2008	B2
7366556	Brister et al.	Apr 2008	B2
7379765	Petisce et al.	May 2008	B2
7381184	Funderburk et al.	Jun 2008	B2
7402153	Steil et al.	Jul 2008	B2
7416541	Yuzhakov et al.	Aug 2008	B2
7424318	Brister et al.	Sep 2008	B2
7455663	Bikovsky	Nov 2008	B2
7460898	Brister et al.	Dec 2008	B2
7462264	Heller et al.	Dec 2008	B2
7467003	Brister et al.	Dec 2008	B2
7471972	Rhodes et al.	Dec 2008	B2
7494465	Brister et al.	Feb 2009	B2
7497827	Brister et al.	Mar 2009	B2
7499002	Blasko et al.	Mar 2009	B2
7519408	Rasdal et al.	Apr 2009	B2
7583990	Goode, Jr. et al.	Sep 2009	B2
7591801	Brauker et al.	Sep 2009	B2
7599726	Goode, Jr. et al.	Oct 2009	B2
7604592	Freeman et al.	Oct 2009	B2
7613491	Boock et al.	Nov 2009	B2
7615007	Shults et al.	Nov 2009	B2
7632228	Brauker et al.	Dec 2009	B2
7637868	Saint et al.	Dec 2009	B2
7640048	Dobbles et al.	Dec 2009	B2
7651596	Petisce et al.	Jan 2010	B2
7654956	Brister et al.	Feb 2010	B2
7657297	Simpson et al.	Feb 2010	B2
7666149	Simons et al.	Feb 2010	B2
7697967	Stafford	Apr 2010	B2
7705653	Schell	Apr 2010	B2
7705980	Smous et al.	Apr 2010	B2
7711402	Shults et al.	May 2010	B2
7713574	Brister et al.	May 2010	B2
7715893	Kamath et al.	May 2010	B2
7722536	Godnow et al.	May 2010	B2
7727147	Osorio et al.	Jun 2010	B1
7731657	Stafford	Jun 2010	B2
7736344	Moberg et al.	Jun 2010	B2
7741734	Joannopoulos et al.	Jun 2010	B2
7763042	Iio et al.	Jul 2010	B2
7766829	Sloan et al.	Aug 2010	B2
7771352	Shults et al.	Aug 2010	B2
7774145	Brauker et al.	Aug 2010	B2
7775444	DeRocco et al.	Aug 2010	B2
7779332	Karr et al.	Aug 2010	B2
7780827	Bhullar et al.	Aug 2010	B1
7782192	Jeckelmann et al.	Aug 2010	B2
7783333	Brister et al.	Aug 2010	B2
7791467	Mazar et al.	Sep 2010	B2
7792562	Shults et al.	Sep 2010	B2
7822454	Alden et al.	Oct 2010	B1
7826981	Goode et al.	Nov 2010	B2
7831310	Lebel et al.	Nov 2010	B2
7860574	Von Arx et al.	Dec 2010	B2
7873299	Berner et al.	Jan 2011	B2
7882611	Shah et al.	Feb 2011	B2
7883464	Stafford	Feb 2011	B2
7899511	Shults et al.	Mar 2011	B2
7905833	Brister et al.	Mar 2011	B2
7912674	Killoren Clark et al.	Mar 2011	B2
7914460	Melker et al.	Mar 2011	B2
7920907	McGarraugh et al.	Apr 2011	B2
7946985	Mastrototaro et al.	May 2011	B2
7955258	Goscha et al.	Jun 2011	B2
7970448	Shults et al.	Jun 2011	B2
7974672	Shults et al.	Jul 2011	B2
7976466	Ward et al.	Jul 2011	B2
7999674	Kamen	Aug 2011	B2
8010174	Goode et al.	Aug 2011	B2
8072310	Everhart	Dec 2011	B1
8090445	Ginggen	Jan 2012	B2
8093991	Stevenson et al.	Jan 2012	B2
8094009	Allen et al.	Jan 2012	B2
8098159	Batra et al.	Jan 2012	B2
8098160	Howarth et al.	Jan 2012	B2
8098161	Lavedas	Jan 2012	B2
8098201	Choi et al.	Jan 2012	B2
8098208	Ficker et al.	Jan 2012	B2
8102021	Degani	Jan 2012	B2
8102154	Bishop et al.	Jan 2012	B2
8102263	Yeo et al.	Jan 2012	B2
8102789	Rosar et al.	Jan 2012	B2
8103241	Young et al.	Jan 2012	B2
8103325	Swedlow et al.	Jan 2012	B2
8111042	Bennett	Feb 2012	B2
8112240	Fennell	Feb 2012	B2
8115488	McDowell	Feb 2012	B2
8116681	Baarman	Feb 2012	B2
8116683	Baarman	Feb 2012	B2
8117481	Anselmi et al.	Feb 2012	B2
8120493	Burr	Feb 2012	B2
8124452	Sheats	Feb 2012	B2
8130093	Mazar et al.	Mar 2012	B2
8131365	Zhang et al.	Mar 2012	B2
8131565	Dicks et al.	Mar 2012	B2
8132037	Fehr et al.	Mar 2012	B2
8135352	Langsweirdt et al.	Mar 2012	B2
8136735	Arai et al.	Mar 2012	B2
8138925	Downie et al.	Mar 2012	B2
8140160	Pless et al.	Mar 2012	B2
8140168	Olson et al.	Mar 2012	B2
8140299	Siess	Mar 2012	B2
8150321	Winter et al.	Apr 2012	B2
8150516	Levine et al.	Apr 2012	B2
8179266	Hermle	May 2012	B2
8180423	Mang et al.	May 2012	B2
8373544	Pitt-Pladdy	Feb 2013	B2
8512243	Stafford	Aug 2013	B2
8515518	Ouyang et al.	Aug 2013	B2
8545403	Peyser et al.	Oct 2013	B2
8585591	Sloan et al.	Nov 2013	B2
8602991	Stafford	Dec 2013	B2
8617071	Say et al.	Dec 2013	B2
8622903	Jin et al.	Jan 2014	B2
8628498	Safabash et al.	Jan 2014	B2
8652043	Drucker et al.	Feb 2014	B2
8684930	Feldman et al.	Apr 2014	B2
8692655	Zimman et al.	Apr 2014	B2
8771183	Sloan	Jul 2014	B2
8797163	Finkenzeller	Aug 2014	B2
8961413	Teller et al.	Feb 2015	B2
9014774	Mao et al.	Apr 2015	B2
9031630	Hoss et al.	May 2015	B2
9060805	Goodnow et al.	Jun 2015	B2
9066697	Peyser et al.	Jun 2015	B2
9402544	Yee et al.	Aug 2016	B2
20010011224	Brown	Aug 2001	A1
20010037060	Thompson et al.	Nov 2001	A1
20010039504	Linberg et al.	Nov 2001	A1
20010054217	Wang	Dec 2001	A1
20020013538	Teller	Jan 2002	A1
20020019022	Dunn et al.	Feb 2002	A1
20020022855	Bobroff et al.	Feb 2002	A1
20020023852	McIvor et al.	Feb 2002	A1
20020026111	Ackerman	Feb 2002	A1
20020029157	Marchosky	Mar 2002	A1
20020042090	Heller et al.	Apr 2002	A1
20020049617	Lencki et al.	Apr 2002	A1
20020054320	Ogino	May 2002	A1
20020055711	Lavi et al.	May 2002	A1
20020055855	Cule et al.	May 2002	A1
20020072784	Sheppard et al.	Jun 2002	A1
20020072858	Cheng	Jun 2002	A1
20020076966	Carron et al.	Jun 2002	A1
20020082487	Kollias et al.	Jun 2002	A1
20020082850	Panelli	Jun 2002	A1
20020103499	Perez et al.	Aug 2002	A1
20020106709	Potts et al.	Aug 2002	A1
20020107476	Mann et al.	Aug 2002	A1
20020111832	Judge	Aug 2002	A1
20020119711	VanAntwerp et al.	Aug 2002	A1
20020128594	Das et al.	Sep 2002	A1
20020130042	Kuhr et al.	Sep 2002	A1
20020133066	Miller et al.	Sep 2002	A1
20020154050	Krupp et al.	Oct 2002	A1
20020161288	Shin et al.	Oct 2002	A1
20020161290	Chance	Oct 2002	A1
20020165462	Westbrook et al.	Nov 2002	A1
20020169369	Ward et al.	Nov 2002	A1
20020169635	Shillingburg	Nov 2002	A1
20020170148	Mayne et al.	Nov 2002	A1
20020188424	Grinstein et al.	Dec 2002	A1
20020188748	Blackwell et al.	Dec 2002	A1
20020198444	Ughigaki et al.	Dec 2002	A1
20030004403	Drinan et al.	Jan 2003	A1
20030023317	Brauker et al.	Jan 2003	A1
20030023461	Quintanilla et al.	Jan 2003	A1
20030028089	Galley et al.	Feb 2003	A1
20030032077	Itoh et al.	Feb 2003	A1
20030032867	Crothall et al.	Feb 2003	A1
20030032874	Rhodes et al.	Feb 2003	A1
20030038047	Sleva et al.	Feb 2003	A1
20030040661	Abraham et al.	Feb 2003	A1
20030040821	Case	Feb 2003	A1
20030042137	Mao et al.	Mar 2003	A1
20030047575	Enkerlin et al.	Mar 2003	A1
20030053665	Hamid	Mar 2003	A1
20030055679	Soll et al.	Mar 2003	A1
20030058245	Brazhnik et al.	Mar 2003	A1
20030060692	Ruchti et al.	Mar 2003	A1
20030060753	Starkweather et al.	Mar 2003	A1
20030063524	Niemiec et al.	Apr 2003	A1
20030064751	Charlier et al.	Apr 2003	A1
20030065308	Lebel et al.	Apr 2003	A1
20030065534	McCartney	Apr 2003	A1
20030069510	Semler	Apr 2003	A1
20030069753	Brown	Apr 2003	A1
20030078481	McIvor et al.	Apr 2003	A1
20030078560	Miller et al.	Apr 2003	A1
20030088238	Poulsen et al.	May 2003	A1
20030097092	Flaherty	May 2003	A1
20030097279	deLusignan et al.	May 2003	A1
20030100040	Bonnecaze et al.	May 2003	A1
20030100821	Heller et al.	May 2003	A1
20030106917	Shetler et al.	Jun 2003	A1
20030109775	O'Neil et al.	Jun 2003	A1
20030110059	Janas et al.	Jun 2003	A1
20030120516	Perednia	Jun 2003	A1
20030134347	Heller et al.	Jul 2003	A1
20030135333	Aceti et al.	Jul 2003	A1
20030144581	Conn et al.	Jul 2003	A1
20030144608	Kojima et al.	Jul 2003	A1
20030155656	Chiu	Aug 2003	A1
20030158707	Doi	Aug 2003	A1
20030158754	Elkind	Aug 2003	A1
20030163351	Brown et al.	Aug 2003	A1
20030168338	Gao et al.	Sep 2003	A1
20030176933	Lebel et al.	Sep 2003	A1
20030187338	Say et al.	Oct 2003	A1
20030199739	Gordon et al.	Oct 2003	A1
20030199790	Boecker et al.	Oct 2003	A1
20030199910	Boecker et al.	Oct 2003	A1
20030208110	Mault et al.	Nov 2003	A1
20030208113	Mault et al.	Nov 2003	A1
20030212379	Bylund et al.	Nov 2003	A1
20030216630	Jersey-Willuhn et al.	Nov 2003	A1
20030217966	Tapsak et al.	Nov 2003	A1
20030225324	Anderson et al.	Dec 2003	A1
20030225361	Sabra	Dec 2003	A1
20030229514	Brown	Dec 2003	A2
20030231552	Markart	Dec 2003	A1
20030233257	Matian et al.	Dec 2003	A1
20030236738	Lange et al.	Dec 2003	A1
20040002682	Kovelman et al.	Jan 2004	A1
20040010207	Flaherty et al.	Jan 2004	A1
20040011671	Shults et al.	Jan 2004	A1
20040014069	Cohen et al.	Jan 2004	A1
20040035897	Salentine et al.	Feb 2004	A1
20040039298	Abreu	Feb 2004	A1
20040040840	Mao et al.	Mar 2004	A1
20040041749	Dixon	Mar 2004	A1
20040044548	Marshall et al.	Mar 2004	A1
20040045879	Shults et al.	Mar 2004	A1
20040054263	Moerman et al.	Mar 2004	A1
20040056055	Folmer	Mar 2004	A1
20040059201	Ginsberg	Mar 2004	A1
20040063435	Sakamoto et al.	Apr 2004	A1
20040064068	DeNuzzio et al.	Apr 2004	A1
20040072357	Steine et al.	Apr 2004	A1
20040073266	Haefner et al.	Apr 2004	A1
20040078215	Dahlin et al.	Apr 2004	A1
20040096959	Steine et al.	May 2004	A1
20040106858	Say et al.	Jun 2004	A1
20040106859	Say et al.	Jun 2004	A1
20040116847	Wall	Jun 2004	A1
20040116866	Gorman et al.	Jun 2004	A1
20040122353	Shahmirian et al.	Jun 2004	A1
20040122489	Mazar et al.	Jun 2004	A1
20040133164	Funderburk et al.	Jul 2004	A1
20040133462	Smith et al.	Jul 2004	A1
20040135684	Steinthal et al.	Jul 2004	A1
20040138544	Ward et al.	Jul 2004	A1
20040138588	Saikley et al.	Jul 2004	A1
20040138688	Giraud	Jul 2004	A1
20040140211	Broy et al.	Jul 2004	A1
20040146909	Duong et al.	Jul 2004	A1
20040147996	Miazga et al.	Jul 2004	A1
20040152622	Keith et al.	Aug 2004	A1
20040152961	Carlson et al.	Aug 2004	A1
20040155079	Shetler et al.	Aug 2004	A1
20040158207	Hunn et al.	Aug 2004	A1
20040165211	Herrmann et al.	Aug 2004	A1
20040167801	Say et al.	Aug 2004	A1
20040171910	Moore-Steele	Sep 2004	A1
20040171921	Say et al.	Sep 2004	A1
20040172284	Sullivan et al.	Sep 2004	A1
20040172307	Gruber	Sep 2004	A1
20040176672	Silver et al.	Sep 2004	A1
20040176913	Kawatahara et al.	Sep 2004	A1
20040186362	Brauker et al.	Sep 2004	A1
20040186365	Jin et al.	Sep 2004	A1
20040193090	Lebel et al.	Sep 2004	A1
20040195284	Iitsuka	Oct 2004	A1
20040197846	Hockersmith et al.	Oct 2004	A1
20040199059	Brauker et al.	Oct 2004	A1
20040199409	Brown	Oct 2004	A1
20040200867	Chee	Oct 2004	A1
20040204687	Mogensen et al.	Oct 2004	A1
20040204863	Kim et al.	Oct 2004	A1
20040204868	Maynard et al.	Oct 2004	A1
20040210458	Evans et al.	Oct 2004	A1
20040223985	Dunfiled et al.	Nov 2004	A1
20040225338	Lebel et al.	Nov 2004	A1
20040232180	Badillo	Nov 2004	A1
20040236200	Say et al.	Nov 2004	A1
20040236251	Roe et al.	Nov 2004	A1
20040254433	Bandis et al.	Dec 2004	A1
20040254434	Goodnow et al.	Dec 2004	A1
20040260155	Ciarniello et al.	Dec 2004	A1
20040260478	Schwamm	Dec 2004	A1
20040267300	Mace	Dec 2004	A1
20050003470	Nelson et al.	Jan 2005	A1
20050004439	Shin et al.	Jan 2005	A1
20050004494	Perez et al.	Jan 2005	A1
20050006122	Burnette	Jan 2005	A1
20050010269	Lebel et al.	Jan 2005	A1
20050022274	Campbell et al.	Jan 2005	A1
20050023137	Bhullar et al.	Feb 2005	A1
20050027177	Shin et al.	Feb 2005	A1
20050027180	Goode, Jr. et al.	Feb 2005	A1
20050031689	Shults et al.	Feb 2005	A1
20050038680	McMahon	Feb 2005	A1
20050043598	Goode, Jr. et al.	Feb 2005	A1
20050045685	Goode, Jr. et al.	Mar 2005	A1
20050048194	Sesto	Mar 2005	A1
20050049179	Davidson et al.	Mar 2005	A1
20050055243	Shmulewitz	Mar 2005	A1
20050059873	Arndt et al.	Mar 2005	A1
20050065555	Er	Mar 2005	A1
20050070819	Poux et al.	Mar 2005	A1
20050071752	Marlatt	Mar 2005	A1
20050085872	Yanagihara et al.	Apr 2005	A1
20050090607	Tapsak et al.	Apr 2005	A1
20050090850	Thoes et al.	Apr 2005	A1
20050092791	Labarca et al.	May 2005	A1
20050096511	Fox et al.	May 2005	A1
20050096512	Fox et al.	May 2005	A1
20050096520	Maekawa et al.	May 2005	A1
20050106713	Phan et al.	May 2005	A1
20050112169	Brauker et al.	May 2005	A1
20050113653	Fox et al.	May 2005	A1
20050114068	Chey et al.	May 2005	A1
20050116683	Cheng et al.	Jun 2005	A1
20050121322	Say et al.	Jun 2005	A1
20050131311	Leuthardt et al.	Jun 2005	A1
20050131346	Douglas	Jun 2005	A1
20050137530	Campbell et al.	Jun 2005	A1
20050143635	Kamath et al.	Jun 2005	A1
20050154271	Rasdal et al.	Jul 2005	A1
20050154410	Conway et al.	Jul 2005	A1
20050165404	Miller	Jul 2005	A1
20050171512	Flaherty	Aug 2005	A1
20050173245	Feldman et al.	Aug 2005	A1
20050176136	Burd et al.	Aug 2005	A1
20050177398	Watanabe et al.	Aug 2005	A1
20050182306	Sloan	Aug 2005	A1
20050182366	Vogt et al.	Aug 2005	A1
20050187720	Goode et al.	Aug 2005	A1
20050192557	Brauker et al.	Sep 2005	A1
20050195930	Spital et al.	Sep 2005	A1
20050197554	Polcha	Sep 2005	A1
20050199494	Say et al.	Sep 2005	A1
20050203360	Brauker et al.	Sep 2005	A1
20050203461	Flaherty et al.	Sep 2005	A1
20050203707	Tsutsui et al.	Sep 2005	A1
20050222518	Dib	Oct 2005	A1
20050222599	Czernecki et al.	Oct 2005	A1
20050236277	Imran et al.	Oct 2005	A9
20050238507	Dilanni et al.	Oct 2005	A1
20050239154	Feldman et al.	Oct 2005	A1
20050239156	Drucker et al.	Oct 2005	A1
20050241957	Mao et al.	Nov 2005	A1
20050245795	Goode, Jr. et al.	Nov 2005	A1
20050245799	Brauker et al.	Nov 2005	A1
20050245839	Stivoric et al.	Nov 2005	A1
20050245844	Mace et al.	Nov 2005	A1
20050256417	Rischell et al.	Nov 2005	A1
20050260174	Fraser et al.	Nov 2005	A1
20050261558	Eaton et al.	Nov 2005	A1
20050271996	Sporbert et al.	Nov 2005	A1
20050267327	Iizuka et al.	Dec 2005	A1
20050267780	Ray et al.	Dec 2005	A1
20050277164	Drucker et al.	Dec 2005	A1
20050281234	Kawamura et al.	Dec 2005	A1
20050281706	Funke et al.	Dec 2005	A1
20050283114	Bresina et al.	Dec 2005	A1
20050283386	Powers et al.	Dec 2005	A1
20050287620	Heller et al.	Dec 2005	A1
20050288571	Perkins et al.	Dec 2005	A1
20060001538	Kraft et al.	Jan 2006	A1
20060001551	Kraft et al.	Jan 2006	A1
20060004270	Bedard et al.	Jan 2006	A1
20060004303	Weidenhaupt et al.	Jan 2006	A1
20060004603	Peterka et al.	Jan 2006	A1
20060004607	Marshall et al.	Jan 2006	A1
20060006141	Ufer et al.	Jan 2006	A1
20060010098	Goodnow et al.	Jan 2006	A1
20060015020	Neale et al.	Jan 2006	A1
20060015024	Brister et al.	Jan 2006	A1
20060016700	Brister et al.	Jan 2006	A1
20060019327	Brister et al.	Jan 2006	A1
20060020186	Brister et al.	Jan 2006	A1
20060020187	Brister et al.	Jan 2006	A1
20060020188	Kamath et al.	Jan 2006	A1
20060020189	Brister et al.	Jan 2006	A1
20060020190	Kamath et al.	Jan 2006	A1
20060020191	Brister et al.	Jan 2006	A1
20060020192	Brister et al.	Jan 2006	A1
20060029177	Cranford, Jr. et al.	Feb 2006	A1
20060031094	Cohen et al.	Feb 2006	A1
20060036134	Tarassenko et al.	Feb 2006	A1
20060036139	Brister et al.	Feb 2006	A1
20060036140	Brister et al.	Feb 2006	A1
20060036141	Kamath et al.	Feb 2006	A1
20060036142	Brister et al.	Feb 2006	A1
20060036143	Brister et al.	Feb 2006	A1
20060036144	Brister et al.	Feb 2006	A1
20060036145	Brister et al.	Feb 2006	A1
20060041229	Garibotto et al.	Feb 2006	A1
20060047220	Sokoto et al.	Mar 2006	A1
20060051738	Zweig	Mar 2006	A1
20060058612	Dave et al.	Mar 2006	A1
20060058626	Weiss et al.	Mar 2006	A1
20060063135	Mehl	Mar 2006	A1
20060079740	Silver et al.	Apr 2006	A1
20060094952	Ma et al.	May 2006	A1
20060095225	Harmon et al.	May 2006	A1
20060115790	Alon et al.	Jun 2006	A1
20060129173	Wilkinson	Jun 2006	A1
20060129328	Leo et al.	Jun 2006	A1
20060143041	Tipirneni	Jun 2006	A1
20060154642	Scannell	Jul 2006	A1
20060155180	Brister et al.	Jul 2006	A1
20060155210	Beckman et al.	Jul 2006	A1
20060155317	List	Jul 2006	A1
20060166629	Reggiardo	Jul 2006	A1
20060167718	Tischer	Jul 2006	A1
20060173260	Gaoni et al.	Aug 2006	A1
20060173444	Choy et al.	Aug 2006	A1
20060178633	Garibotto et al.	Aug 2006	A1
20060183985	Brister et al.	Aug 2006	A1
20060189863	Peyser et al.	Aug 2006	A1
20060189939	Gononelli et al.	Aug 2006	A1
20060195029	Shults et al.	Aug 2006	A1
20060200970	Brister et al.	Sep 2006	A1
20060202805	Schulman et al.	Sep 2006	A1
20060222566	Brauker et al.	Oct 2006	A1
20060224141	Rush et al.	Oct 2006	A1
20060226985	Goodnow et al.	Oct 2006	A1
20060235009	Glickman et al.	Oct 2006	A1
20060240549	Minton	Oct 2006	A1
20060241969	Wilhide et al.	Oct 2006	A1
20060244465	Kroh et al.	Nov 2006	A1
20060247508	Fennell	Nov 2006	A1
20060247710	Goetz et al.	Nov 2006	A1
20060258929	Goode, Jr. et al.	Nov 2006	A1
20060264888	Moberg et al.	Nov 2006	A1
20060272652	Stocker et al.	Dec 2006	A1
20060276724	Freeman et al.	Dec 2006	A1
20060282042	Walters et al.	Dec 2006	A1
20060282290	Flaherty et al.	Dec 2006	A1
20060287691	Drew	Dec 2006	A1
20070010950	Abensour et al.	Jan 2007	A1
20070012324	Nirkondar et al.	Jan 2007	A1
20070016381	Kamath et al.	Jan 2007	A1
20070016449	Cohen et al.	Jan 2007	A1
20070027381	Stafford	Feb 2007	A1
20070033074	Nitzan et al.	Feb 2007	A1
20070033114	Minor	Feb 2007	A1
20070038044	Dobbles et al.	Feb 2007	A1
20070041626	Weiss et al.	Feb 2007	A1
20070055799	Koehler et al.	Mar 2007	A1
20070060814	Stafford	Mar 2007	A1
20070060979	Strother et al.	Mar 2007	A1
20070061170	Lorsch et al.	Mar 2007	A1
20070066873	Kamath et al.	Mar 2007	A1
20070066956	Finkel	Mar 2007	A1
20070067000	Strother et al.	Mar 2007	A1
20070071681	Gadkar et al.	Mar 2007	A1
20070073129	Shah et al.	Mar 2007	A1
20070074043	Lacey	Mar 2007	A1
20070078320	Stafford	Apr 2007	A1
20070078321	Mazza et al.	Apr 2007	A1
20070078322	Stafford	Apr 2007	A1
20070078323	Reggiardo et al.	Apr 2007	A1
20070078818	Zvitz et al.	Apr 2007	A1
20070093786	Goldsmith et al.	Apr 2007	A1
20070095661	Wang et al.	May 2007	A1
20070096715	Joy et al.	May 2007	A1
20070100215	Powers et al.	May 2007	A1
20070106135	Sloan et al.	May 2007	A1
20070110124	Shiraki et al.	May 2007	A1
20070118405	Campbell et al.	May 2007	A1
20070123819	Mernoe et al.	May 2007	A1
20070124002	Estes et al.	May 2007	A1
20070149861	Crothall et al.	Jun 2007	A1
20070149875	Ouyang et al.	Jun 2007	A1
20070156033	Causey, III et al.	Jul 2007	A1
20070163880	Woo et al.	Jul 2007	A1
20070168224	Letzt et al.	Jul 2007	A1
20070173698	Kivela et al.	Jul 2007	A1
20070173706	Neinast et al.	Jul 2007	A1
20070173741	Deshmukh et al.	Jul 2007	A1
20070173761	Kanderian et al.	Jul 2007	A1
20070179349	Hoyme et al.	Aug 2007	A1
20070179352	Randlov et al.	Aug 2007	A1
20070185390	Perkins et al.	Aug 2007	A1
20070191701	Feldman et al.	Aug 2007	A1
20070203407	Hoss et al.	Aug 2007	A1
20070203539	Stone et al.	Aug 2007	A1
20070203966	Brauker et al.	Aug 2007	A1
20070213611	Simpson et al.	Sep 2007	A1
20070219432	Thompson	Sep 2007	A1
20070219480	Kamen et al.	Sep 2007	A1
20070219597	Kamen et al.	Sep 2007	A1
20070228071	Kamen et al.	Oct 2007	A1
20070231846	Cosentino et al.	Oct 2007	A1
20070232880	Siddiqui et al.	Oct 2007	A1
20070235331	Simpson et al.	Oct 2007	A1
20070244368	Bayloff et al.	Oct 2007	A1
20070244379	Boock et al.	Oct 2007	A1
20070244383	Talbot et al.	Oct 2007	A1
20070244398	Lo et al.	Oct 2007	A1
20070249922	Peyser et al.	Oct 2007	A1
20070253021	Mehta et al.	Nov 2007	A1
20070255302	Koeppel et al.	Nov 2007	A1
20070255531	Drew	Nov 2007	A1
20070258395	Jollota et al.	Nov 2007	A1
20070270672	Hayter	Nov 2007	A1
20070282299	Hellwig	Dec 2007	A1
20070285238	Batra	Dec 2007	A1
20070293932	Zilla et al.	Dec 2007	A1
20080004512	Funderburk et al.	Jan 2008	A1
20080004573	Kaufmann et al.	Jan 2008	A1
20080004904	Tran	Jan 2008	A1
20080009692	Stafford	Jan 2008	A1
20080009805	Ethelfeld	Jan 2008	A1
20080017522	Heller et al.	Jan 2008	A1
20080021666	Goode, Jr. et al.	Jan 2008	A1
20080026338	Cinader	Jan 2008	A1
20080027474	Curry et al.	Jan 2008	A1
20080029391	Mao et al.	Feb 2008	A1
20080030369	Mann et al.	Feb 2008	A1
20080033254	Kamath et al.	Feb 2008	A1
20080033268	Stafford	Feb 2008	A1
20080033318	Mace et al.	Feb 2008	A1
20080039702	Hayter et al.	Feb 2008	A1
20080045824	Tapsak et al.	Feb 2008	A1
20080057484	Miyata et al.	Mar 2008	A1
20080058626	Miyata et al.	Mar 2008	A1
20080058678	Miyata et al.	Mar 2008	A1
20080062891	Van der Merwe et al.	Mar 2008	A1
20080063948	O'Brien	Mar 2008	A1
20080064937	McGarraugh et al.	Mar 2008	A1
20080064941	Funderburk et al.	Mar 2008	A1
20080064943	Talbot et al.	Mar 2008	A1
20080065236	Bristol	Mar 2008	A1
20080065646	Zhang et al.	Mar 2008	A1
20080071156	Brister et al.	Mar 2008	A1
20080071157	McGarraugh et al.	Mar 2008	A1
20080071158	McGarraugh et al.	Mar 2008	A1
20080071328	Haubrich et al.	Mar 2008	A1
20080071580	Marcus et al.	Mar 2008	A1
20080073993	Sortore et al.	Mar 2008	A1
20080077433	Kasprisin et al.	Mar 2008	A1
20080078567	Miller et al.	Apr 2008	A1
20080083617	Simpson et al.	Apr 2008	A1
20080086042	Brister et al.	Apr 2008	A1
20080086044	Brister et al.	Apr 2008	A1
20080086273	Shults et al.	Apr 2008	A1
20080097246	Stafford	Apr 2008	A1
20080097289	Steil et al.	Apr 2008	A1
20080099332	Scott et al.	May 2008	A1
20080105479	Lei	May 2008	A1
20080105748	Lei	May 2008	A1
20080108942	Brister et al.	May 2008	A1
20080112848	Huffstodt et al.	May 2008	A1
20080114228	McCluskey et al.	May 2008	A1
20080114280	Stafford	May 2008	A1
20080119705	Patel et al.	May 2008	A1
20080119707	Stafford	May 2008	A1
20080125636	Ward et al.	May 2008	A1
20080126882	Fulton et al.	May 2008	A1
20080127052	Rostoker	May 2008	A1
20080129465	Rao	Jun 2008	A1
20080133702	Sharma et al.	Jun 2008	A1
20080139910	Mastrototaro et al.	Jun 2008	A1
20080145277	Wohland	Jun 2008	A1
20080154513	Kovatchev et al.	Jun 2008	A1
20080167543	Say et al.	Jul 2008	A1
20080167572	Stivoric et al.	Jul 2008	A1
20080167578	Bryer et al.	Jul 2008	A1
20080172205	Breton et al.	Jul 2008	A1
20080183060	Steil et al.	Jul 2008	A1
20080183061	Goode, Jr. et al.	Jul 2008	A1
20080183399	Goode, Jr. et al.	Jul 2008	A1
20080183500	Banigan	Jul 2008	A1
20080188731	Brister et al.	Aug 2008	A1
20080188796	Steil et al.	Aug 2008	A1
20080189051	Goode, Jr. et al.	Aug 2008	A1
20080194934	Ray et al.	Aug 2008	A1
20080194935	Brister et al.	Aug 2008	A1
20080194936	Goode, Jr. et al.	Aug 2008	A1
20080194937	Goode, Jr. et al.	Aug 2008	A1
20080194938	Brister et al.	Aug 2008	A1
20080195049	Thalmann et al.	Aug 2008	A1
20080195232	Carr-Brendel et al.	Aug 2008	A1
20080195967	Goode, Jr. et al.	Aug 2008	A1
20080197024	Simpson et al.	Aug 2008	A1
20080200788	Brister et al.	Aug 2008	A1
20080200789	Brister et al.	Aug 2008	A1
20080200791	Simpson et al.	Aug 2008	A1
20080200897	Hoss et al.	Aug 2008	A1
20080208025	Shults et al.	Aug 2008	A1
20080208113	Damiano et al.	Aug 2008	A1
20080214915	Brister et al.	Sep 2008	A1
20080214918	Brister et al.	Sep 2008	A1
20080228051	Shults et al.	Sep 2008	A1
20080228054	Shults et al.	Sep 2008	A1
20080228055	Sher	Sep 2008	A1
20080234663	Yodfat et al.	Sep 2008	A1
20080235469	Drew	Sep 2008	A1
20080242961	Brister et al.	Oct 2008	A1
20080255434	Hayter et al.	Oct 2008	A1
20080255437	Hayter	Oct 2008	A1
20080255438	Saidara et al.	Oct 2008	A1
20080255808	Hayter	Oct 2008	A1
20080256048	Hayter	Oct 2008	A1
20080262330	Reynolds et al.	Oct 2008	A1
20080262469	Brister et al.	Oct 2008	A1
20080269673	Butoi	Oct 2008	A1
20080269723	Mastrototaro et al.	Oct 2008	A1
20080275313	Brister et al.	Nov 2008	A1
20080281167	Soderberg et al.	Nov 2008	A1
20080283396	Wang	Nov 2008	A1
20080287761	Hayter	Nov 2008	A1
20080287762	Hayter	Nov 2008	A1
20080287763	Hayter	Nov 2008	A1
20080287764	Rasdal et al.	Nov 2008	A1
20080287765	Rasdal et al.	Nov 2008	A1
20080287766	Rasdal et al.	Nov 2008	A1
20080288180	Hayter	Nov 2008	A1
20080288204	Hayter et al.	Nov 2008	A1
20080294096	Uber et al.	Nov 2008	A1
20080296155	Shults et al.	Dec 2008	A1
20080300476	Stafford	Dec 2008	A1
20080306368	Goode, Jr. et al.	Dec 2008	A1
20080306434	Dobbles et al.	Dec 2008	A1
20080306435	Kamath et al.	Dec 2008	A1
20080306444	Brister et al.	Dec 2008	A1
20080312518	Jina et al.	Dec 2008	A1
20080312841	Hayter	Dec 2008	A1
20080312842	Hayter	Dec 2008	A1
20080312844	Hayter et al.	Dec 2008	A1
20080312845	Hayter et al.	Dec 2008	A1
20090005659	Kollias et al.	Jan 2009	A1
20090005665	Hayter et al.	Jan 2009	A1
20090005666	Shin et al.	Jan 2009	A1
20090006034	Hayter et al.	Jan 2009	A1
20090006133	Weinert et al.	Jan 2009	A1
20090007237	Lorsch	Jan 2009	A1
20090012377	Jennewine et al.	Jan 2009	A1
20090012379	Goode, Jr. et al.	Jan 2009	A1
20090018424	Kamath et al.	Jan 2009	A1
20090018425	Ouyang et al.	Jan 2009	A1
20090018779	Cohen et al.	Jan 2009	A1
20090030294	Petisce et al.	Jan 2009	A1
20090030733	Cohen et al.	Jan 2009	A1
20090033482	Hayter et al.	Feb 2009	A1
20090036747	Hayter et al.	Feb 2009	A1
20090036758	Brauker et al.	Feb 2009	A1
20090036760	Hayter	Feb 2009	A1
20090036763	Brauker et al.	Feb 2009	A1
20090036915	Karbowniczek et al.	Feb 2009	A1
20090043181	Brauker et al.	Feb 2009	A1
20090043182	Brauker et al.	Feb 2009	A1
20090043525	Brauker et al.	Feb 2009	A1
20090043541	Brauker et al.	Feb 2009	A1
20090043542	Brauker et al.	Feb 2009	A1
20090045055	Rhodes et al.	Feb 2009	A1
20090048501	Goodnow	Feb 2009	A1
20090048503	Dalal et al.	Feb 2009	A1
20090054866	Teisen-Simony et al.	Feb 2009	A1
20090055149	Hayter et al.	Feb 2009	A1
20090062633	Brauker et al.	Mar 2009	A1
20090062635	Brauker et al.	Mar 2009	A1
20090062767	VanAntwerp et al.	Mar 2009	A1
20090063402	Hayter	Mar 2009	A1
20090069658	Say	Mar 2009	A1
20090069750	Schraga	Mar 2009	A1
20090076356	Simpson et al.	Mar 2009	A1
20090076359	Peyser	Mar 2009	A1
20090076360	Brister et al.	Mar 2009	A1
20090076361	Kamath et al.	Mar 2009	A1
20090082693	Stafford	Mar 2009	A1
20090085768	Patel et al.	Apr 2009	A1
20090085873	Betts et al.	Apr 2009	A1
20090088427	Clickman et al.	Apr 2009	A1
20090088614	Taub	Apr 2009	A1
20090088787	Koike et al.	Apr 2009	A1
20090099436	Brister et al.	Apr 2009	A1
20090102678	Mazza	Apr 2009	A1
20090105554	Stahman et al.	Apr 2009	A1
20090105560	Solomon	Apr 2009	A1
20090105569	Stafford	Apr 2009	A1
20090105636	Hayter et al.	Apr 2009	A1
20090112478	Mueller, Jr. et al.	Apr 2009	A1
20090124877	Shariati et al.	May 2009	A1
20090124878	Goode et al.	May 2009	A1
20090124879	Brister et al.	May 2009	A1
20090124964	Leach et al.	May 2009	A1
20090131768	Simpson et al.	May 2009	A1
20090131769	Leach et al.	May 2009	A1
20090131776	Simpson et al.	May 2009	A1
20090131777	Simpson et al.	May 2009	A1
20090131860	Nielsen	May 2009	A1
20090137886	Shariati et al.	May 2009	A1
20090137887	Shariati et al.	May 2009	A1
20090143659	Li et al.	Jun 2009	A1
20090143660	Brister et al.	Jun 2009	A1
20090149717	Brauer et al.	Jun 2009	A1
20090150186	Cohen et al.	Jun 2009	A1
20090156919	Brister et al.	Jun 2009	A1
20090156924	Shariati et al.	Jun 2009	A1
20090163790	Brister et al.	Jun 2009	A1
20090163791	Brister et al.	Jun 2009	A1
20090164190	Hayter	Jun 2009	A1
20090164239	Hayter et al.	Jun 2009	A1
20090164251	Hayter	Jun 2009	A1
20090171182	Stafford	Jul 2009	A1
20090178459	Li et al.	Jul 2009	A1
20090182217	Li et al.	Jul 2009	A1
20090187351	Orr et al.	Jul 2009	A1
20090189738	Hermle	Jul 2009	A1
20090192366	Mensinger et al.	Jul 2009	A1
20090192380	Shariati et al.	Jul 2009	A1
20090192722	Shariati et al.	Jul 2009	A1
20090192724	Brauker et al.	Jul 2009	A1
20090192745	Kamath et al.	Jul 2009	A1
20090192751	Kamath et al.	Jul 2009	A1
20090198118	Hayter et al.	Aug 2009	A1
20090198215	Chong et al.	Aug 2009	A1
20090203981	Brauker et al.	Aug 2009	A1
20090204341	Brauker et al.	Aug 2009	A1
20090212766	Olson et al.	Aug 2009	A1
20090216103	Brister et al.	Aug 2009	A1
20090221880	Soderberg et al.	Sep 2009	A1
20090224773	Joy et al.	Sep 2009	A1
20090224837	Joy et al.	Sep 2009	A1
20090227876	Tran et al.	Sep 2009	A1
20090227877	Tran et al.	Sep 2009	A1
20090228304	Ciarniello et al.	Sep 2009	A1
20090234200	Husheer	Sep 2009	A1
20090240120	Mensinger et al.	Sep 2009	A1
20090240127	Ray	Sep 2009	A1
20090240128	Mensinger et al.	Sep 2009	A1
20090240193	Mensinger et al.	Sep 2009	A1
20090242399	Kamath et al.	Oct 2009	A1
20090242425	Kamath et al.	Oct 2009	A1
20090247855	Boock et al.	Oct 2009	A1
20090247856	Boock et al.	Oct 2009	A1
20090247931	Damgaard-Sorensen	Oct 2009	A1
20090253973	Bashan et al.	Oct 2009	A1
20090258790	Cohen et al.	Oct 2009	A1
20090259118	Feldman et al.	Oct 2009	A1
20090267765	Greene et al.	Oct 2009	A1
20090269315	Fraser et al.	Oct 2009	A1
20090270765	Ghesquire et al.	Oct 2009	A1
20090273353	Kroh et al.	Nov 2009	A1
20090278553	Kroh et al.	Nov 2009	A1
20090281519	Rao et al.	Nov 2009	A1
20090287073	Boock et al.	Nov 2009	A1
20090287074	Shults et al.	Nov 2009	A1
20090289796	Blumberg	Nov 2009	A1
20090292184	Funderburk et al.	Nov 2009	A1
20090292185	Funderburk et al.	Nov 2009	A1
20090299155	Yang et al.	Dec 2009	A1
20090299156	Simpson et al.	Dec 2009	A1
20090299162	Brauker et al.	Dec 2009	A1
20090299167	Seymour	Dec 2009	A1
20090299276	Brauker et al.	Dec 2009	A1
20100004597	Gryn et al.	Jan 2010	A1
20100010324	Brauker et al.	Jan 2010	A1
20100010331	Brauker et al.	Jan 2010	A1
20100010332	Brauker et al.	Jan 2010	A1
20100016687	Brauker et al.	Jan 2010	A1
20100016698	Rasdal et al.	Jan 2010	A1
20100022855	Brauker et al.	Jan 2010	A1
20100030038	Brauker et al.	Feb 2010	A1
20100030053	Goode, Jr. et al.	Feb 2010	A1
20100030484	Brauker et al.	Feb 2010	A1
20100030485	Brauker et al.	Feb 2010	A1
20100036215	Goode, Jr. et al.	Feb 2010	A1
20100036216	Goode, Jr. et al.	Feb 2010	A1
20100036222	Goode, Jr. et al.	Feb 2010	A1
20100036223	Goode, Jr. et al.	Feb 2010	A1
20100036225	Goode, Jr. et al.	Feb 2010	A1
20100041971	Goode, Jr. et al.	Feb 2010	A1
20100045465	Brauker et al.	Feb 2010	A1
20100049014	Funderburk et al.	Feb 2010	A1
20100049024	Saint et al.	Feb 2010	A1
20100063373	Kamath et al.	Mar 2010	A1
20100069728	Funderburk et al.	Mar 2010	A1
20100076283	Simpson et al.	Mar 2010	A1
20100081908	Dobbles et al.	Apr 2010	A1
20100081910	Brister et al.	Apr 2010	A1
20100087724	Brauker et al.	Apr 2010	A1
20100088199	Tipirneni	Apr 2010	A1
20100096259	Zhang et al.	Apr 2010	A1
20100099970	Shults et al.	Apr 2010	A1
20100099971	Shults et al.	Apr 2010	A1
20100100113	Iio et al.	Apr 2010	A1
20100105999	Dixon et al.	Apr 2010	A1
20100113897	Brenneman et al.	May 2010	A1
20100119693	Tapsak et al.	May 2010	A1
20100121169	Petisce et al.	May 2010	A1
20100146300	Brown	Jun 2010	A1
20100152554	Steine et al.	Jun 2010	A1
20100160759	Celentano et al.	Jun 2010	A1
20100160760	Shults et al.	Jun 2010	A1
20100161240	Tseng	Jun 2010	A1
20100161269	Kamath et al.	Jun 2010	A1
20100168538	Keenan et al.	Jul 2010	A1
20100168540	Kamath et al.	Jul 2010	A1
20100168541	Kamath et al.	Jul 2010	A1
20100168542	Kamath et al.	Jul 2010	A1
20100168543	Kamath et al.	Jul 2010	A1
20100168544	Kamath et al.	Jul 2010	A1
20100168546	Kamath et al.	Jul 2010	A1
20100168547	Kamath et al.	Jul 2010	A1
20100168645	Kamath et al.	Jul 2010	A1
20100174157	Brister et al.	Jul 2010	A1
20100174158	Kamath et al.	Jul 2010	A1
20100174163	Brister et al.	Jul 2010	A1
20100174164	Brister et al.	Jul 2010	A1
20100174165	Brister et al.	Jul 2010	A1
20100174166	Brister et al.	Jul 2010	A1
20100174167	Kamath et al.	Jul 2010	A1
20100174168	Goode et al.	Jul 2010	A1
20100179399	Goode et al.	Jul 2010	A1
20100179400	Brauker et al.	Jul 2010	A1
20100179401	Rasdal et al.	Jul 2010	A1
20100179402	Goode et al.	Jul 2010	A1
20100179404	Kamath et al.	Jul 2010	A1
20100179405	Goode et al.	Jul 2010	A1
20100179407	Goode et al.	Jul 2010	A1
20100179408	Kamath et al.	Jul 2010	A1
20100179409	Kamath et al.	Jul 2010	A1
20100185065	Goode et al.	Jul 2010	A1
20100185069	Brister et al.	Jul 2010	A1
20100185070	Brister et al.	Jul 2010	A1
20100185071	Simpson et al.	Jul 2010	A1
20100185072	Goode et al.	Jul 2010	A1
20100185073	Goode et al.	Jul 2010	A1
20100185074	Goode et al.	Jul 2010	A1
20100185075	Brister et al.	Jul 2010	A1
20100190435	Cook et al.	Jul 2010	A1
20100191082	Brister et al.	Jul 2010	A1
20100198033	Krulevitch et al.	Aug 2010	A1
20100198034	Thomas et al.	Aug 2010	A1
20100198035	Kamath et al.	Aug 2010	A1
20100198036	Kamath et al.	Aug 2010	A1
20100198142	Sloan et al.	Aug 2010	A1
20100204653	Gryn et al.	Aug 2010	A1
20100212583	Brister et al.	Aug 2010	A1
20100214104	Goode et al.	Aug 2010	A1
20100217105	Yodfat et al.	Aug 2010	A1
20100217557	Kamath et al.	Aug 2010	A1
20100223013	Kamath et al.	Sep 2010	A1
20100223022	Kamath et al.	Sep 2010	A1
20100223023	Kamath et al.	Sep 2010	A1
20100228109	Kamath et al.	Sep 2010	A1
20100228497	Kamath et al.	Sep 2010	A1
20100240975	Goode et al.	Sep 2010	A1
20100240976	Goode et al.	Sep 2010	A1
20100261987	Kamath et al.	Oct 2010	A1
20100262201	He et al.	Oct 2010	A1
20100274107	Boock et al.	Oct 2010	A1
20100280341	Boock et al.	Nov 2010	A1
20100286496	Simpson et al.	Nov 2010	A1
20100298684	Leach et al.	Nov 2010	A1
20100312176	Lauer et al.	Dec 2010	A1
20100324392	Yee et al.	Dec 2010	A1
20100324403	Brister et al.	Dec 2010	A1
20100331642	Bruce et al.	Dec 2010	A1
20100331644	Neale et al.	Dec 2010	A1
20100331648	Kamath et al.	Dec 2010	A1
20100331653	Stafford	Dec 2010	A1
20100331656	Mensinger et al.	Dec 2010	A1
20100331657	Mensinger et al.	Dec 2010	A1
20110004085	Mensinger et al.	Jan 2011	A1
20110004276	Blair et al.	Jan 2011	A1
20110009727	Mensinger et al.	Jan 2011	A1
20110024043	Boock et al.	Feb 2011	A1
20110024307	Simpson et al.	Feb 2011	A1
20110027127	Simpson et al.	Feb 2011	A1
20110027453	Boock et al.	Feb 2011	A1
20110027458	Boock et al.	Feb 2011	A1
20110028815	Simpson et al.	Feb 2011	A1
20110028816	Simpson et al.	Feb 2011	A1
20110040256	Bobroff et al.	Feb 2011	A1
20110040263	Hordum et al.	Feb 2011	A1
20110046467	Simpson et al.	Feb 2011	A1
20110046977	Goodnow et al.	Feb 2011	A1
20110054275	Stafford	Mar 2011	A1
20110060196	Stafford	Mar 2011	A1
20110073475	Kastanos et al.	Mar 2011	A1
20110077490	Simpson et al.	Mar 2011	A1
20110082484	Saravia et al.	Apr 2011	A1
20110106126	Love et al.	May 2011	A1
20110118579	Goode et al.	May 2011	A1
20110118580	Goode et al.	May 2011	A1
20110124992	Brauker et al.	May 2011	A1
20110124997	Goode et al.	May 2011	A1
20110125410	Goode et al.	May 2011	A1
20110130970	Goode et al.	Jun 2011	A1
20110130971	Goode et al.	Jun 2011	A1
20110130998	Goode et al.	Jun 2011	A1
20110137257	Gyrn et al.	Jun 2011	A1
20110144465	Shults et al.	Jun 2011	A1
20110145172	Petisce et al.	Jun 2011	A1
20110148905	Simmons et al.	Jun 2011	A1
20110152637	Kateraas et al.	Jun 2011	A1
20110178378	Brister et al.	Jul 2011	A1
20110178461	Chong et al.	Jul 2011	A1
20110184258	Stafford	Jul 2011	A1
20110190603	Stafford	Aug 2011	A1
20110190614	Brister et al.	Aug 2011	A1
20110201910	Rasdal et al.	Aug 2011	A1
20110201911	Johnson et al.	Aug 2011	A1
20110218414	Kamath et al.	Sep 2011	A1
20110231107	Brauker et al.	Sep 2011	A1
20110231140	Goode et al.	Sep 2011	A1
20110231141	Goode et al.	Sep 2011	A1
20110231142	Goode et al.	Sep 2011	A1
20110253533	Shults et al.	Oct 2011	A1
20110257895	Brauker et al.	Oct 2011	A1
20110263958	Brauker et al.	Oct 2011	A1
20110270062	Goode et al.	Nov 2011	A1
20110270158	Brauker et al.	Nov 2011	A1
20110275919	Petisce et al.	Nov 2011	A1
20110288574	Curry et al.	Nov 2011	A1
20110290645	Brister et al.	Dec 2011	A1
20110313543	Brauker et al.	Dec 2011	A1
20110319729	Donnay et al.	Dec 2011	A1
20110319733	Stafford	Dec 2011	A1
20110319738	Woodruff et al.	Dec 2011	A1
20110319739	Kamath et al.	Dec 2011	A1
20110320130	Valdes et al.	Dec 2011	A1
20120010642	Lee et al.	Jan 2012	A1
20120035445	Boock et al.	Feb 2012	A1
20120040101	Tapsak et al.	Feb 2012	A1
20120046534	Simpson et al.	Feb 2012	A1
20120078071	Bohm et al.	Mar 2012	A1
20120108934	Valdes et al.	May 2012	A1
20120108983	Banet et al.	May 2012	A1
20120190989	Kaiser et al.	Jul 2012	A1

Foreign Referenced Citations (70)

Number	Date	Country
4401400	Jul 1995	DE
0098592	Jan 1984	EP
0127958	Dec 1984	EP
0320109	Jun 1989	EP
0353328	Feb 1990	EP
0390390	Oct 1990	EP
0396788	Nov 1990	EP
0286118	Jan 1995	EP
1048264	Nov 2000	EP
1177802	Feb 2002	EP
0987982	Jan 2007	EP
2060284	May 2009	EP
2201969	Jun 2010	EP
2327362	Jun 2011	EP
2335587	Jun 2011	EP
11-506629	Jun 1999	JP
2003-527138	Sep 2003	JP
2004-520103	Jul 2004	JP
2004-520898	Jul 2004	JP
2006-517804	Aug 2006	JP
WO-1996039977	May 1996	WO
WO-1996025089	Aug 1996	WO
WO-1996035370	Nov 1996	WO
WO-1997021457	Jun 1997	WO
WO-1998035053	Aug 1998	WO
WO-1998056293	Dec 1998	WO
WO-1999033504	Jul 1999	WO
WO-1999056613	Nov 1999	WO
WO-2000049940	Aug 2000	WO
WO-2000059370	Oct 2000	WO
WO-2000072181	Nov 2000	WO
WO-2000075814	Dec 2000	WO
WO-2000078992	Dec 2000	WO
WO-2001052935	Jul 2001	WO
WO-2001054753	Aug 2001	WO
WO-2002016905	Feb 2002	WO
WO-2002050534	Jun 2002	WO
WO-2002058537	Aug 2002	WO
WO-2003028784	Apr 2003	WO
WO-2003041231	May 2003	WO
WO-2003049597	Jun 2003	WO
WO-2003073936	Sep 2003	WO
WO-2003076893	Sep 2003	WO
WO-2003082091	Oct 2003	WO
WO-2004054445	Jul 2004	WO
WO-2004060436	Jul 2004	WO
WO-2004061420	Jul 2004	WO
WO-2004110256	Dec 2004	WO
WO-2005040793	May 2005	WO
WO-2005045744	May 2005	WO
WO-2005084534	Sep 2005	WO
WO-2005089103	Sep 2005	WO
WO-2005119524	Dec 2005	WO
WO-2006026741	Mar 2006	WO
WO-2006032653	Mar 2006	WO
WO-2006042811	Apr 2006	WO
WO-2006069657	Jul 2006	WO
WO-2006086423	Aug 2006	WO
WO-2006108809	Oct 2006	WO
WO-2006124099	Nov 2006	WO
WO-2007041069	Apr 2007	WO
WO-2007140783	Dec 2007	WO
WO-2007143225	Dec 2007	WO
WO-2008001366	Jan 2008	WO
WO-2008065646	Jun 2008	WO
WO-2008133702	Nov 2008	WO
WO-2009062675	May 2009	WO
WO-20100112521	Oct 2010	WO
WO-2011002815	Jan 2011	WO
WO-2011022418	Feb 2011	WO

Non-Patent Literature Citations (128)

Entry
Alcock, et al., “Continuous analyte monitoring to aid clinical practice,” IEEE Engineering in Medicine & BioloXY Magazine, 13:319-25 (1994).
Amour, J.C. et al., “Application of Chronic Intravascular Blood Glucose Sensor in Dogs,” Diabetes, vol. 39, 1990, pp. 1519-1526.
Bennion, N. et al., “Alternate Site Glucose Testing: A Crossover Design,” Diabetes Technology & Therapeutics, vol. 4, No. 1, 2002, pp. 25-33.
Bendt, D. J., et al., “Introduction to the Minitrack: Databases, Data Warehousing, and Data Mining in Health Care,” System Sciences, Proceedings of 33rd Annual Hawaii International Conference, Jan. 4-7, 2000, pp. 1588.
Bindra, D.S. et al., “Design and in Vitro Studies of a Needle-Type Glucose Sensor for Subcutaneous Monitoring,” Anal. Chem., 63(17):1692-1696 (Sep. 1, 1991).
Blank, T.B. et al., “Clinical Results from a Non-Invasive Blood Glucose Monitor,” Optical Diagnostics and Sensing of Biological Fluids and Glucose and Cholesterol Monitoring II, Proceedings of SPIE, vol. 4624, 2002, pp. 1-10.
Bobbioni-Harsch, E. et al., “Lifespan of subcutaneous glucose sensors and their performances during dynamic glycaemia changes in rats,” J. Biomed. Eng. 15:457-463 (1993).
Brooks, S.L. et al., “Development of an On-Line Glucose Sensor for Fermentation Monitoring,” Biosensors, vol. 3, 1987/88, pp. 45-56.
Bühling et al., Journal of Perinatal Medicine, 2005, vol. 33, pp. 125-131.
Cass, A.E. et al., “Ferrocene-Medicated Enzyme Electrode for Amperometric Determination of Glucose,” Analytical Chemistry, vol. 56, No. 4, 1984, pp. 667-671.
Cheyne, E.H. et al., “Performance of a Continuous Glucose Monitoring System During Controlled Hypoglycaemia in Healthy Volunteers,” Diabetes Technology & Therapeutics, vol. 4, No. 5, 2002, pp. 607-613.
Csoegi, E. et al., “Design and Optimization of a Selective Subcutaneously Implantable Glucose Electrode Based on ‘Wired’ Glucose Oxidase,” Analytical Chemistry, vol. 67, No. 7, 1995, pp. 1240-1244.
Cullen, M.T., et al., “The Changing Presentations of Diabetic Ketoacidosis During Pregnancy,” Amer. J. Perinatol, 1996, vol. 13, No. 7, pp. 449-451 (abstract only).
Feldman, B. et al., “A Continuous Glucose Sensor Based on Wired Enzyme™ Technology—Results from a 3-Day Trial in Patients with Type 1 Diabetes,” Diabetes Technology & Therapeutics, vol. 5, No. 5, 2003, pp. 769-779.
Feldman, B. et al., “Correlation of Glucose Concentrations in Interstitial Fluid and Venous Blood During Periods of Rapid Glucose Change,” Abbott Diabetes Case, Inc. Freestyle Navigator Continuous Glucose Monitor Pamphlet, 2004.
Gunasingham, et al., “Electrochemically Modulated Optrode for Glucose,” Biosensors & Bioelectronics, vol. 7, 1992, pp. 353-359.
Gregg, B. A. et al., “Cross-Linked Redox Gels Containing Glucose Oxidase for Amperometric Biosensor Applications,” Analytical Chemistry, 62(3):258-263 (Feb. 1, 1990).
Harrison, D.J. et al., “Characterization of Perfluorosulfonic Acid Polymer Coated Enzyme Electrodes and a Miniaturized Integrated Potentiostat for Glucose Analysis in Whole Blood,” Anal. Chem., 60 (19):2002-2007 (Oct. 1, 1988).
Heller, A., “Electrical Connection of Enzyme Redox Centers to Electrodes,” J. Phys. Chem., 96 (9):3579-3587 (1992).
Heller, A., “Electrical Wiring of Redox Enzymes,” Acc. Chem. Res., 23(5):129-134 (1990).
Ikeda, T., et al., “Artificial Pancreas—Investigation of the Stability of Glucose Sensors Using a Telemetry System” (English language translation of abstract), Jpn. J. Artif. Organs, vol. 19, No. 2, 1990, 889-892.
Isermann, R., “Supervision, Fault-Detection and Fault-Diagnosis Methods—An Introduction”, Control Engineering Practice, vol. 5, No. 5, 1997, pp. 639-652.
Isermann, R. et al., “Trends in the Application of Model-Based Fault Detection and Diagnosis of Technical Processes”, Control Engineering Practice, vol. 5, No. 5, 1997, pp. 709-719.
Johnson, K., et al., “In vivo evaluation of an electroenzymatic glucose sensor implanted in subcutaneous tissue,” Biosensors and Bioelectronics, 1992, vol. 7, pp. 709-714.
Johnson, P.C., “Peripheral Circulation,” John Wiley & Sons, 1978, pp. 198.
Jovanovic, Diabetes Technology & Therapeutics, 2000, vol. 2, Supplement 1, pp. S-67-S-71.
Jungheim, K. et al., “How Rapid Does Glucose Concentration Change in Daily Life of Patients with Type 1 Diabetes?”, 2002, pp. 250.
Jungheim, K. et al., “Risky Delay of Hypoglycemia Detection by Glucose Monitoring at the Arm”, Diabetes Care, vol. 24, No. 7, 2001, pp. 1303-1304.
Kaplan, S. M., “Wiley Electrical and Electronics Engineering Dictionary”, IEEE Press, 2004, pp. 141, 142, 548, 549.
Lodwig, V. et al., “Continuous Glucose Monitoring with Glucose Sensors: Calibration and Assessment Criteria,” Diabetes Technology & Therapeutics, vol. 5, No. 4, 2003, pp. 573-587.
Lortz, J. et al., “What is Bluetooth? We Explain the Newest Short-Range Connectivity Technology”, Smart Computing Learning Series, Wireless Computing, vol. 8, Issue 5, 2002, pp. 72-74.
Maidan, R. et al., “Elimination of Electroaxidizable Interferant -Produced Currents in Amperometric Biosensors,” Analytical Chemistry, 64(23):2889-2896 (Dec. 1, 1992).
Malin, S.F. et al., “Noninvasive Prediction of Glucose by Near-Infrared Diffuse Reflectance Spectoscopy,” Clinical Chemistry, vol. 45, No. 9, 1999, pp. 1651-1658.
Mastrototaro, J. J. et al., “An Electroenzymatic Glucose Sensor Fabricated on a Flexible Substrate,” Sensors and Biosensors B Chemical, B5:139-144 (1991).
McGarraugh, G. et al., “Glucose Measurements Using Blood Extracted from the Forearm and the Finger,” TheraSense, Inc., 2001, 16 pages.
McGarraugh, G. et al., “Physiological Influences on Off-Finger Glucose Testing,” Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 367-376.
McKean, B. D. et al., “A Telemetry-Instrumentation System for Chronically Implanted Glucose and Oxygen Sensors”, IEEE Transactions on Biomedical Engineering, vol. 35, No. 7, 1988, pp. 526-532.
MiniMed Technologies, “Tape Tips and Other Infusion Site Information,” 1995.
Moatti-Sirat, D. et al., “Towards continuous glucose monitoring: in vivo evaluation of a miniaturized glucose sensor implanted for several days in rat subcutaneous tissue,” Diabetolocia, 35(3) (1 page—Abstract only) (Mar. 1992).
Morbiducci, U. et al., “Improved Usability of the Minimal Model of Insulin Sensitivity Based on an Automated Approach and Genetic algorithms for Parameter Estimation,” Clinical Science, vol. 112, 2007, pp. 257-263.
Mougiakakou et al., “A Real Time Simulation Model of Glucose-Insulin Metabolism for Type 1 Diabetes Patients,” Proceedings of the 2005 IEEE, 2005, pp. 298-301.
Ohara, T. J. et al., “Glucose Electrodes Based on Cross-Linked [Os(bpy).sub.2 C1].sup. +/2+ Complexed Poly(I-vinylimadazole) Films,” Analytical Chemistry, 65(23):3512-3516 (Dec. 1, 1993).
Opinion of the Court, Supreme Court of the United States, No. 04-1350, KSR International co., Petitioner v. Teleflex Inc. et al., Apr. 30, 2007.
Pickup, J. et al., “Implantable Glucose Sensors: Choosing the Appropriate Sensing Strategy,” Biosensors, vol. 3, 1987/88, pp. 335-346.
Pickup, J. et al., “In Vivo Molecular Sensing in Diabetes Mellitus: An Implantable Glucose Sensor with Direct Electron Transfer,” Diabetologia, vol. 32, 1989, pp. 213-217.
Parker, R. et al., “Robust H∞ Glucose Control in Diabetes Using a Physiological Model,” AIChE Journal, vol. 46, No. 12, 2000, pp. 2537-2549.
Pishko, M.V. et al., “Amperometric Glucose Microelectrodes Prepared Through Immobilization of Glucose Oxidase in Redox Hydrogels,” Analytical Chemistry, vol. 63, No. 20, 1991, pp. 2268-2272.
Poitout, V. et al., “In vitro and in vivo evaluation in dogs of a miniaturized glucose sensor,” ASAIO Transactions, 37(3) (1 page—Abstract only) (Jul.-Sep. 1991).
Quinn, C.P. et al., Kinetics of Glucose Delivery to Subcutaneous Tissue in Rats Measured with 0.3-mm Amperometric Microsensors, The American Physiological Society, 1995, E155-E161.
Reach, G. et al., “Can Continuous Glucose Monitoring Be Used for the Treatment of Diabetes?” Analytical Chemistry, 64(6):381-386 (Mar. 15, 1992).
Rebrin, K. et al., “Automated Feedback Control of Subcutaneous Glucose Concentration in Diabetic Dogs,” Diabetologia, 32(8):573-576 (Aug. 1989).
Roe, J.N. et al., “Bloodless Glucose Measurements,” Critical Review in Therapeutic Drug Carrier Systems, vol. 15, Issue 3, 1998, pp. 199-241.
Sakakida, M. et al., “Development of Ferrocene-Mediated Needle-Type Glucose Sensor as a Measure of True Subcutaneous Tissue Glucose Concentration,” Artificial Organs Today, vol. 2, No. 2, 1992, pp. 145-158.
Sakakida, M. et al., “Ferrocene-Medicated Needle-Type Glucose Sensor Covered with Newly Designed Biocompatible Membrane,” Sensors and Actuators B, vol. 13-14, 1993, pp. 319-322.
Salehi, C. et al., “A Telemetry-Instrumentation System for Long-Term Implantable Glucose and Oxygen Sensors”, Analytical Letters, vol. 29, No. 13, 1996, pp. 2289-2308.
Schmidt, F. J., et al., “Calibration of a Wearable Glucose Sensor”, The International Journal of Artificial Organs, vol. 15, No. 1, 1992, pp. 55-61.
Schmidtke, D.W. et al., “Measurement and Modeling of the Transient Difference Between Blood and Subcutaneous Glucose Concentrations in the Rat After Injection of Insulin,” Proceedings of the National Academy of Sciences, vol. 95, 1998, pp. 294-299.
Shaw, G. W. et al., “In Vitro Testing of a Simply Constructed, Highly Stable Glucose Sensor Suitable for Implantation in Diabetic Patients”, Biosensors & Bioelectronics, vol. 6, 1991, pp. 401-406.
Shichiri, M. et al., “Glycaemic Control in Pancreatectomized Dogs with a Wearable Artificial Endocrine Pancreas,” Diabetologia, vol. 24, 1983, pp. 179-184.
Shichiri, M. et al., “In Vivo Characteristics of Needle-Type Glucose Sensor—Measurements of Subcutaneous Glucose Concentrations in Human Volunteers,” Hormone and Metabolic Research Supplement Series, vol. 20, 1988, pp. 17-20.
Shichiri, M. et al., “Membrane Design for Extending the Long-Life of an Implantable Glucose Sensor,” Diabetes Nutrition and Metabolism, vol. 2, 1989, pp. 309-313.
Shichiri, M. et al., “Needle-Type Glucose Sensor for Wearable Artificial Endocrine Pancreas,” Implantable Sensors for Closed-Loop Prosthetic Systems, Chapter 15, 1985, pp. 197-210.
Shichiri, M. et al., “Telemetry Glucose Monitoring Device with Needle-Type Glucose Sensor: A Useful Tool for Blood Glucose Monitoring in Diabetic Individuals”, Diabetes Care, vol. 9, No. 3, 1986, pp. 298-301.
Shichiri, M. et al., “Wearable Artificial Endocrine Pancreas with Needle-Type Glucose Sensor,” The Lancet, 1982, pp. 1129-1131.
Shults, M. C. et al., “A Telemetry-Instrumentation System for Monitoring Multiple Subcutaneously Implanted Glucose Sensors”, IEEE Transactions on Biomedical Engineering, vol. 41, No. 10, 1994, pp. 937-942.
Sternberg, R. et al., “Study and Development of Multilayer Needle-Type Enzyme-Based Glucose Microsensors,” Biosensors, vol. 4, 1988, pp. 27-40.
Thompson, M. et al., “In Vivo Probes: Problems and Perspectives,” Clinical Biochemistry, vol. 19, 1986, pp. 255-261.
Travenol Laboratories, Inc., An Introduction of “Eugly,” Book 1, 1985, pp. 1-22.
Turner, A. et al., “Diabetes Mellitus: Biosensors for Research and Management,” Biosensors, vol. 1, 1985, pp. 85-115.
Updike, S. J. et al., “Principles of Long-Term Fully Implanted Sensors with Emphasis on Radiotelemetric Monitoring of Blood Glucose from Inside a Subcutaneous Foreign Body Capsule (FBC)”, Biosensors in the Body: Continuous in vivo Monitoring, Chapter 4, 1997, pp. 117-137.
Velho, G. et al., “Strategies for Calibrating a Subcutaneous Glucose Sensor”, Biomedica Biochimica Acta, vol. 48, 1989, pp. 957-964.
Wang et al., Journal of the Shanghai Medical University, 2000, vol. 27, pp. 393-395 (Abstract).
Wilson, G.S. et al., “Progress Toward the Development of an Implantable Sensor for Glucose,” Clinical Chemistry, vol. 38, No. 9, 1992, pp. 1613-1617.
Ye, L. et al., “High Current Density “Wired” Quinoprotein Glucose Dehydrogenase Electroade,” Anal. Chem., 65(3):238-241 (Feb. 1, 1993).
Canadian Patent Application No. CA-2,752,455, Examiner's Report dated Jun. 13, 2012.
Canadian Patent Application No. CA-2,858,901, Examiner's Report dated Jan. 25, 2016.
Chinese Patent Application No. 200880005149.1, Notification of Granting a Patent Right for an Invention dated Jun. 21, 2013.
Chinese Patent Application No. 200880005149.1, Original Language and English Translation of Office Action dated Aug. 17, 2011.
Chinese Patent Application No. 200880005149.1, Original Language and English Translation of Office Action dated Dec. 3, 2012.
Chinese Patent Application No. 200880005149.1, Original Language and English Translation of Office Action dated Feb. 16, 2012.
Chinese Patent Application No. 200880005149.1, Original Language and English Translation of Office Action dated Jul. 29, 2010.
European Patent Application No. EP-05756627.5, Supplementary European Search Report dated Dec. 4, 2009.
European Patent Application No. EP-05756627.5, Office Action dated Jun. 24, 200.
European Patent Application No. EP-05756627.5, Decision to Refuse the Application dated Dec. 12, 2013.
European Patent Application No. EP-05756627.5, Decision to Refuse the Application dated Dec. 7, 2012.
European Patent Application No. EP-05756627.5, Examination Report dated Jun. 7, 2013.
European Patent Application No. EP-05756627.5, Official Communication dated Jun. 13, 2012.
PCT Application No. PCT/US2005/020044, International Preliminary Report on Patentability dated Dec. 20, 2006.
PCT Application No. PCT/US2008/054165, International Preliminary Report on Patentability and Written Opinion of the International Searching Authority dated Aug. 27, 2009.
PCT Application No. PCT/US2008/054165, International Search Report and Written Opinion of the International Searching Authority dated Jun. 5, 2008.
PCT Application No. PCT/US2008/067791, International Search Report and Written Opinion of the International Searching Authority dated Sep. 29, 2008.
PCT Application No. PCT/US2008/067791, International Search Report on Patentability and Written Opinion of the International Searching Authority dated Jan. 7, 2010.
PCT Application No. PCT/US2010/022860, International Search Report and Written Opinion dated Mar. 23, 2010.
PCT Application No. PCT/US2010/022860, International Preliminary Report on Patentability and Written Opinion of the International Searching Authority dated Aug. 18, 2011.
PCT Application No. PCT/US2010/047381, International Search Report and Written Opinion dated Oct. 15, 2010.
PCT Application No. PCT/US2010/047381, International Preliminary Report on Patentability and Written Opinion of the International Searching Authority dated Mar. 15, 2012.
PCT Application No. PCT/US2010/050772, International Search Report and Written Opinion dated Dec. 3, 2010.
PCT Application No. PCT/US2010/050772, International Preliminary Report on Patentability and Written Opinion of the International Searching Authority dated Apr. 12, 2012.
PCT Application No. PCT/US2010/050888, International Search Report and Written Opinion dated Nov. 29, 2010.
PCT Application No. PCT/US2010/050888, International Preliminary Report on Patentability and Written Opinion of the International Searching Authority dated Apr. 12, 2012.
PCT Application No. PCT/US2010/051861, International Search Report and Written Opinion dated Nov. 30, 2010.
PCT Application No. PCT/US2010/051861, International Preliminary Report on Patentability and Written Opinion of the International Searching Authority dated Apr. 19, 2012.
Russian Patent Application No. 2009134334, Original Language and English Translation of Office Action dated Feb. 7, 2012.
U.S. Appl. No. 12/893,974, Office Action dated Mar. 28, 2013.
U.S. Appl. No. 90/008,457, Request for Reexamination of U.S. Pat. No. 6,990,366, filed Jan. 23, 2007.
U.S. Appl. No. 90/009,104 & U.S. Appl. No. 90/009,328, Notice of Intent to Issue Reexamination Certificate dated Nov. 20, 2009.
U.S. Appl. No. 90/009,104 & U.S. Appl. No. 90/009,328, Office Action dated Aug. 4, 2009.
U.S. Appl. No. 90/009,104 & U.S. Appl. No. 90/009,328, Office Action dated Sep. 30, 2009.
U.S. Appl. No. 90/009,104, Office Action dated Oct. 16, 2008.
U.S. Appl. No. 90/009,104, Order Granting Request for Reexamination mailed Jun. 5, 2008.
U.S. Appl. No. 90/009,104, Request for Reexamination of U.S. Patent No. 6,990,366 filed Apr. 8, 2008.
U.S. Appl. No. 90/009,328, Order Granting Request for Reexamination mailed Dec. 9, 2008.
U.S. Appl. No. 90/009,328, Request for Reexamination of U.S. Pat. No. 6,990,366 filed Nov. 10, 2008.
U.S. Appl. No. 90/010,791, Notice of Intent to Issue Reexamination Certificate dated May 17, 2011.
U.S. Appl. No. 90/010,791, Office Action dated Dec. 17, 2010.
U.S. Appl. No. 90/010,791, Office Action dated May 28, 2010.
U.S. Appl. No. 90/010,791, Order Granting Request for Reexamination mailed Feb. 22, 2010.
U.S. Appl. No. 90/010,791, Request for Reexamination of U.S. Pat. No. 6,990,366 filed Dec. 22, 2009.
U.S. Appl. No. 90/011,730, Notice of Intent to Issue Reexam Certificate for U.S. Patent No. 6,990,366 dated Apr. 5, 2012.
U.S. Appl. No. 90/011,730, Office Action dated Jan. 11, 2012.
U.S. Appl. No. 90/011,730, Order Granting Request for Reexamination of U.S. Patent No. 6,990,366 mailed Aug. 24, 2011.
U.S. Appl. No. 90/011,730, Request for Reexamination of U.S. Pat. No. 6,990,366 filed Jun. 3, 2011.
U.S. Appl. No. 95/002,113, Order Denying Request for Reexamination of U.S. Pat. No. 6,990,366 mailed Nov. 13, 2012.
U.S. Appl. No. 95/002,113, Petition for Review of the Order Denying Request Reexamination of U.S. Patent No. 6,990,366 mailed Dec. 13, 2012.
U.S. Appl. No. 95/002,113, Request for Reexamination of U.S. Patent No. 6,990,366 filed Aug. 30, 2012.
U.S. Appl. No. 95/002,162, Order Denying Request for Reexamination of U.S. Pat. No. 8,175,673 mailed Nov. 13, 2012.
U.S. Appl. No. 95/002,162, Petition for Review of the Order Denying Request Reexamination of U.S. Pat. No. 8,175,673 mailed Dec. 13, 2012.
U.S. Appl. No. 95/002,162, Request for Reexamination of U.S. Patent No. 8,175,673 filed Sep. 7, 2012.

Related Publications (1)

	Number	Date	Country
	20210113118 A1	Apr 2021	US

Provisional Applications (1)

	Number	Date	Country
	61247516	Sep 2009	US

Continuations (4)

	Number	Date	Country
Parent	16941717	Jul 2020	US
Child	17137785		US
Parent	15674439	Aug 2017	US
Child	16941717		US
Parent	15140309	Apr 2016	US
Child	15674439		US
Parent	12895015	Sep 2010	US
Child	15140309		US

Interconnect for on-body analyte monitoring device

Information

Patent Number

Date Filed

Date Issued

Inventors

Original Assignees

Examiners

Agents

CPC

Field of Search

CPC

International Classifications

Abstract